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ABSTRACT
Interaction Between Primary Alveolar Macrophages And Primary Alveolar Type II
Cells Under Basal Conditions
And After Lipopolysaccharide Or Quartz Exposure

Rania S. Kanj
Evidence suggests that hyperproduction of reactive oxidants and inflammatory mediators
plays a critical role in adverse pulmonary responses to silica or lipopolysaccharide (LPS).
The main objective of this study was to contribute to advancing the understanding of the
role of AM’s and type II (TII) cells in the induction of pulmonary inflammation and
injury in response to silica and LPS, and improve our understanding of the interaction
between AM’s and TII cells which would occur in vivo. To reach this objective, three
aims were put forth. 1) Determine the relative responsiveness of primary rat AM’s,
primary rat TII cells and RLE-6TN, a rat TII cell line to silica and LPS under comparable
conditions. 2) Determine if AM/TII intercellular interactions exist and under what
conditions they can be demonstrated. 3) Attempt to identify the mediator(s) responsible
for this interaction. The following findings were made: 1) although AM’s were generally
found to release more inflammatory mediators than TII cells following LPS or silica
exposures, primary TII cells clearly produced significant levels of mediators which could
be capable of contributing considerably to lung inflammation and injury. 2) Since the
RLE-6TN cell line responses to LPS and silica exposures were generally considerably
less intense and required higher doses of stimulant than those measured in primary TII
cells, RLE-6TN cells may not be a good substitute for primary TII cells in studying the
pulmonary epithelium. 3) LPS was more potent than silica in inducing inflammatory
cytokines from the three cell types. However, silica was found to be as potent as LPS or
even slightly more potent as an inducer of cellular oxidants, especially from primary TII
cells. 4) Surfactant appears to be an inhibitory mediator released from TII cells and acts
on AM’s. 5) Basal transwell co-culture conditions are better than mixed co-culture
conditions to study AM/TII cell interactions since the inhibitory effect of the surfactant in
the transwell co-culture is minimized. 6) Oxidants, TNF-alpha, IL-1beta, prostaglandins
and leukotrienes, probably do not directly affect the AM/TII intercellular interaction;
instead, they (and especially TNF-alpha) appear to indirectly modulate the complex
pathways of the AM/TII communication.
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Introduction
The lung can be susceptible to disease because of its direct contact with the outside
environment. Alveolar macrophages (AM’s) phagocytize and clear inhaled microbes and
particles, therefore, playing an important role in lung defense. However, when exposed
to high dust burdens, AM’s secrete reactive products and cytokines, which can cause lung
inflammation and damage. This excessive inflammation is believed to play a critical role
in occupational lung diseases, such as silicosis and toxic pneumonitis (Zhang et al.,
2000). Recent evidence suggests that alveolar type II epithelial cells (TII) may also
contribute to lung inflammation (Blau et al., 1994; Crippen et al., 1995; Finkelstein et al.,
1997).
Main objective: Contribute to advancing the understanding of the role of AM’s and TII
cells in the induction of pulmonary inflammation and injury in response to silica and
LPS, and improve our understanding of the interaction between AM’s and TII cells which
would occur in vivo.
Aim 1: Determine the relative responsiveness of AM’s, primary TII cells and a TII cell
line to silica and LPS under comparable conditions.
Aim 2: Determine if intercellular interactions exist and under what conditions they can be
demonstrated.
Aim 3: Attempt to identify the mediator(s) responsible for this interaction.
The three cell types used in this study are primary rat AM’s, primary rat TII cells, and
RLE-6TN, a rat TII cell line.
Alveolar macrophages (AM’s):
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AM’s are the alveolar derivatives of blood monocytes and are located at the air/tissue
interface within the surfactant lining of the alveolar region. These cells are the first line
of defense against outside contaminants and invaders (Lohmann-Matthes et al., 1994).
AM’s are the phagocytes of the alveolar region. With the variety of membrane receptors
they possess (Johansson et al., 1997), AM’s are able to bind a variety of particles and
compounds including LPS (Martin, 1999) and silica (Kobzik, 1995; Iyer et al., 1996).
Once binding has occurred, AM’s engulf inhaled particles and migrate up the mucociliary
escalator or enter the lymphatic ducts to be cleared from the lung (Stober and McClellan,
1997). Phagocytizing AM’s can produce reactive oxygen species through a respiratory or
oxidative burst that directly contributes to killing microorganisms (Johnson, 1978).
AM’s are also capable of directly killing viruses by producing interferon (Hahon and
Castranova, 1989). When incapable of killing foreign organisms by themselves, AM’s
recruit more phagocytic cells to the area by releasing chemokines, such as macrophageinflammatory protein-2 (MIP-2), which acts to attract polymorphonuclear leukocytes
(PMN’s), monocytes and other cells from the pulmonary capillaries to the alveolar
airspaces (Nielson et al., 1995).
Type II alveolar epithelial cells (TII):
TII cells comprise about 4% of the alveolar epithelial surface, but they constitute
approximately 60% of the alveolar epithelial cell population in number (Crapo et al.,
1983). For a long time, they have been known to synthesize, store and secrete the
surfactant material lining the alveoli. Such production and release of surfactant has been
demonstrated using both in vivo (Askin and Kuhn, 1971) and in vitro (Mason et al., 1980;
Miles et al., 1988) model systems. Surfactant consists mainly of phospholipids (Sanders
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and Longmore, 1975) and proteins, and its role in decreasing surface tension and, thus,
decreasing the work required to inflate the lungs was demonstrated by Clements (1957
and 1977). However, other roles have also been attributed to surfactant, such as
enhancement of bacterial phagocytosis and killing by AM’s (O’Neil et al., 1984) and
decreasing the cytotoxicity of inhaled particles by coating their surface (Wallace et al.,
1985). TII cells are also an important site for xenobiotic metabolism and are strategically
located in close contact with both the pulmonary air and blood phases. In effect, TII cells
are capable of detoxifying or toxifying foreign substances, since they’re rich in
endoplasmic reticulum (ER) which exhibits P-450-dependent monooxygenase activity
(Castranova et al., 1988). TII cells have another important role in the lungs, which is to
maximize gas exchange. This is accomplished by the transcellular transport of Na+ and
H2O, thereby, keeping the alveoli dry and preventing edema (Jones et al., 1983). Indeed,
TII monolayers in culture exhibit "Dome" formation as Na+ is passively transported into
the cell at the luminol side and actively transported to the blood at the basolateral side,
and water follows (Mason et al., 1982: Castranova et al., 1988). Regeneration of the
alveolar epithelium is another important role played by TII cells in the lungs, where TII
cells have the ability to proliferate following injury (Panos et al., 1990) and dedifferentiate into TI cells to repair the alveolar epithelium (Leslie et al., 1985). TII cells
also contribute to protecting the lung from oxidant injury since they have specialized
pathways for the uptake of antioxidants, such as vitamin C and taurine (Castranova et al.,
1983; Banks et al., 1989), which help in resistance to oxidant damage. Like AM’s, TII
cells play a major antiviral role by producing interferon upon viral exposure (Hahon and
Castranova, 1989). They can also produce NO., ROS and cytokines in response to
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different stimulants (Punjabi et al., 1994) and, thus, contribute to cell recruitment in
response to an inflammatory agent and microbial killing (Crippen et al., 1995).
Rat lung epithelial-T-antigen negative (RLE-6TN) cells:
Rat lung epithelial-T-antigen negative, or RLE-6TN cells were derived from alveolar TII
cells by Kevin Driscoll et al. (1995a). Like primary TII cells, RLE-6TN cells contain
lamellar bodies for surfactant storage, and they have the ability to produce cytokines, NO.
and other ROS when stimulated (Stringer and Kobzik, 1998; Driscoll et al., 2001).
Unlike primary TII cells, RLE-6TN cells maintain their morphology and the ability to
produce surfactant even after a long time in culture (few days).
Of major importance to lung pathology are two main airborne contaminants: silica and
lipopolysaccharide (LPS).
Silica:
Silica or silicon dioxide (SiO2), mostly in its quartz crystalline form, is a common
mineral found in most rocks around us (Peters, 1986). Being highly fibrogenic and
biologically toxic, it can bind to membrane receptors on target cells, including AM’s
(through their surface scavenger receptors) and TII cells (Kobzik et al., 1995; Iyer et al.,
1996). Silica can directly cause cellular toxicity. It can also initiate an inflammatory
response that could include increased oxidant production and proinflammatory mediator
secretion as a result of nuclear transcription factor-κB (NF-κB) activation (Kang et al.,
2000; Vallyathan and Shi, 1997) in target and recruited cells. Such events could
eventually lead to lung injury and fibrosis (Castranova, 1998 and 2000 a) or even lung
cancer (Driscoll et al., 1997). Cleavage of crystalline silica, as in rock drilling, tunneling
and sand blasting, results in the generation of the highly toxic silicon-based radicals (Si.
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and Si-O. ). Upon inhalation, these surface radicals can then interact with water
molecules, producing the highly toxic hydroxyl radicals (OH. ) and other radicals
(Vallyathan et al., 1988; Castranova, 1994). Many industry-related occupations have a
relatively high silica exposures. In fact, among the highest exposure occupations are rock
drilling, sandblasting, tunneling, silica flour mill operations, stone grinding, and ceramic
making (Castranova and Vallyathan, 2000 b). Through either acute or chronic exposures,
silica particles can result in biopersistence in the lung alveolar spaces (Stober and
McClellan, 1997), leading to cell damage, release of inflammatory mediators, and in
many cases lung fibrosis or silicosis (Donaldson and Tran, 2002). Among the symptoms
accompanying acute silicosis are pulmonary edema, interstitial inflammation and
alveolitis, alveolar epithelial hypertrophy and hyperplasia, and increased surfactant
phospholipid release by alveolar TII cells (Driscoll et al., 1990; Porter et al., 2001). With
chronic silicosis, silicotic nodules, characterized by collagen deposited in a spiral pattern,
can be recognized mainly in the upper lung lobes (Castranova and Vallyathan, 2000 b).
LPS:
LPS is a lipid-carbohydrate component of gram-negative bacterial endotoxin, which is
the bacteria’s outer cell membrane complex. Endotoxin, including the active LPS
component, can be associated with indoor or outdoor organic dust particles, if humidity
and temperature conditions are favorable to microbial growth. Endotoxin exposure can
occur in agricultural settings, such as silo unloading or poultry processing, as well as in
textile industry, wastewater treatment and other occupations (Burrell, 1997).
One of the many ways through which LPS can be recognized by target cells is by binding
with an LPS binding protein (LPB) to CD 14 cellular membrane receptors (Martin,

5

1999). Other LPS cell membrane receptors are Toll Like Receptors (TLR) (Chen et al.,
2002). This recognition is capable of triggering a cell signaling cascade that usually
involves modification of G proteins and activation of protein kinase C in a calciumdependent fashion. Although recognition and intracellular signaling can differ with target
cell and type of receptor LPS binds to, the result of this binding with most target cells is
usually the stimulus for an inflammatory response (Blau et al., 1994), which could be
associated with many inflammatory lung diseases. The cellular signaling cascade
triggered by LPS binding to target cells is thought to induce synthesis of inducible nitric
oxide synthase (iNOS), activation of NAD(P) oxidase, activation of cyclooxygenase-2
(COX-2), and activation of many transcription regulatory factors like NF-κB (Calvano et
al., 2003). Activation of NF-κB stimulates the synthesis and release of many
inflammatory mediators, such as the pro-inflammatory cytokines TNF-α, IL-β, and IL-6,
( Chen et al., 1995; Christman et al., 1998). Acute exposure to LPS is associated with
diseases such as byssinosis, acute respiratory distress syndrome (ARDS) and sepsis,
whereas a chronic exposure is associated with lung diseases, such as asthma, chronic
bronchitis, chronic obstructive pulmonary disease (COPD), chronic byssinosis and other
serious lung diseases. A typical LPS lung inflammation is usually accompanied by fever,
chills, cough, and tightness of chest caused by pulmonary edema. Also, symptoms of
chronic LPS exposure are typical for a chronic lung inflammation and include
peribronchial and perivascular lymphatic aggregates, alveolar and airway changes
including alveolar enlargement, airway wall thickening and mucus cell metaplasia
(Vernooy et al., 2002). LPS exposure is also characterized by a elevated PMN number in
the bronchoalveolar lavage (BAL) fluid.
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The end-points which were investigated in the present study were reactive oxygen species
(ROS), nitric oxide (NO. ), tumor necrosis factor-α (TNF-α), macrophage inflammatory
protein-2 (MIP-2), interleukin-1β (IL-1β), and interleukin-6 (IL-6).
Reactive oxygen species (ROS):
Although oxygen is vital for energy generation by mammalian cells via aerobic oxidative
metabolism, some oxygen metabolites can be very toxic to cells if produced excessively.
Such oxygen metabolites are termed reactive oxygen species or reactive oxygen
intermediates (ROS or ROI) and include the hydroxyl radical (OH. ), superoxide radical
(O2-. ) and hydrogen peroxide (H2O2) (Castranova, 1998). In resting cells, mitochondrial
“leakage” is one of the main sources for ROS, whereby 2-4% of the oxygen consumed
for ATP production is reduced to O2-. rather than water (Chen and Castranova, 2003).
This “leakage” could increase upon cellular activation, since cellular respiration
increases. Another main site for ROS formation is the membrane-bound multisubunit
enzyme complex termed NADPH oxidase. This enzyme is usually dormant in resting
cells and is activated upon complexation of cytosolic and membrane subunits as a result
of cell binding to a stimulus (Babior, 1999). When cells like AM’s and TII bind toxic
substances like LPS or silica, high levels of ROS are generated that can overwhelm the
cells’ antioxidant capacity and cause oxidative stress. ROS are generally very unstable
and highly reactive. They can cause direct cell damage by oxidizing lipids (Dalal et al.,
1990), proteins, carbohydrates, and DNA which confer to ROS a microbicidal and
tumoricidal role (Johnston, 1978). They can also cause indirect cell and /or tissue
damage by inducing cellular production of other pro-inflammatory mediators, such as
TNF-α, MIP-2, IL-1β, IL-6 and other mediators regulated by NF-κB and AP-1 nuclear
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transcription factors (Comhair and Erzurum, 2002). The main set of chemical reactions
leading to ROS generation include the following (Chen and Castranova, 2004):
+

2 O2 +NADPH + H

NADPH
→
2 O2-. + NADP+ + 2H+
oxidase

2 O2-. + 2H+ → H2O2 + O2
O2-. + H2O2 →OH. + OH- + O2
Substantial evidence exists that support the ability of AM’s and TII cells to release ROS
upon stimulation. Indeed macrophage release of ROS upon LPS (Chandel et al., 2000)
and silica (Kang et al., 2000) exposure has been suggested to be a mediator in NF-κB
activation and TNF-α and MIP-2 release (Barrett et al., 1999 b). Also, TII cells release
of ROS has been detected in a murine TII cell line (MLE-15) upon silica exposure using
an oxidant sensitive dye (Barrett et al., 1999 a). ROS production has also been detected
in a rat TII cell line (RLE-6TN) (Driscoll et al., 2001).
Nitric oxide (NO. ):
Similar to ROS, reactive nitrogen species (RNS), such as nitric oxide (NO. ), nitrite (NO2)
and peroxynitrite (ONOO-), are vital for normal cell functioning but can be toxic if
produced excessively by stimulated cells. Also similar to ROS, RNS are generally very
unstable and highly reactive. They can cause direct or indirect cell and /or tissue damage
by inducing both oxidizing and/or nitrating cellular damage (Jorens et al., 1993). RNS
may also induce production of other pro-inflammatory mediators, such as TNF-α, MIP-2,
IL-1β, IL-6 and other mediators regulated by activator protein-1 (AP-1) and nuclear
transcription factor-κB (NF-κB) (Comhair and Erzurum, 2002; Chen and Castranova,
2003). NO. gas is released as a by-product of the conversion of L-arginine to L-citruline,
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catalyzed by the enzyme nitric oxide synthase (NOS). Of the three types of the cytosolic
NOS enzymes, the calcium independent NOS II (or iNOS), which is the inducible form,
has been the one mostly linked with reactive stress caused by overactivation of the
enzyme upon its synthesis following cell stimulation (Comhair and Erzurum, 2002;
Jorens et al., 1993). The main chemical reactions of NO. resulting in the generating of
reactive oxidants include (Castranova, 1998):
NO. + O2-. → OONO –
OONO - + H+ → HOONO → OH. + NO2
NO. release from primary AM’s following in vivo silica exposure has been shown to
increase significantly compared to control. In contrast, NO. release from AM’s
following in vitro silica exposure was not significantly enhanced (Huffman et al., 1998).
Also, mRNA for iNOS significantly increased in AM’s following intratracheal (IT)
instillation of silica (Castranova, 1998). Whereas silica exposure seems to require the
intercellular communication found in vivo to induce NO. synthesis from AM’s, LPS has
been shown to induce both NO. and iNOS mRNA synthesis in macrophages following
both in vivo (Blackford et al., 1994) and in vitro (Punjabi et al., 1994; Rao et al., 1999)
LPS exposure. As for TII cells, iNOS enzyme and mRNA release have been reported to
be significantly increased following in vivo LPS (Toga et al., 2001) or silica (Porter et al.,
2002 b) exposure.
Cytokines and chemokines:
Cytokines are multifunctional extracellular signaling polypeptide mediators of cell
behavior and intercellular communication involved in maintaining a steady-state lung
environment under resting conditions, but are also involved in many ways upon tissue
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injury (Kelley, 1990). Cytokines exert their action by binding to their specific surface
receptors on target cells ( Christman et al., 1998) and triggering a cascade of intracellular
events that could lead to diverse effects through activation of various transcription
factors. Similar to ROS, an imbalance between anti and pro- inflammatory cytokines in
favor of the latter could result in tissue inflammation and injury (Martin, 1999).
Chemokines are chemotactic mediators that help recruit inflammatory cells like PMN’s,
monocytes, lymphocytes, and macrophages to sites of microbial or particle deposition
(Driscoll et al., 1996 a).
Tumor necrosis factor-alpha (TNF-α): TNF-α is a very important inflammatory cytokine
synthesized as an early response mediator in cellular stimulation (Martin, 1999). It’s a
mediator in the recruitment and activation of inflammatory cells, cell proliferation, and
extracellular matrix protein synthesis (Driscoll, 1995 and 1996 b). It can stimulate the
production of other pro-inflammatory cytokines, such as MIP-2 (Driscoll et al., 1996 a;
Barrett et al., 1999 a) and IL-6 (Crestani et al., 1994), and other mediators such as ROS
and NO. through the activation of NF-κB (Driscoll et al., 2001; Barrett et al., 1999 a),
and/or other cellular components. Primary AM’s have been reported to produce
increased TNF levels upon exposure to LPS or silica in vitro compared to control (Dubois
et al., 1989). Also, TNF-α mRNA and protein has been shown to increase upon LPS or
silica exposure compared to control in a murine macrophages cell line (RAW 264. 7)
(Chen et al., 1995; Barrett et al., 1999 b). In addition, TII cells’ TNF-α levels have been
shown to increase following LPS (McRitchie et al., 2000; Haddad et al., 2002) or silica
(Finkelstein et al., 1997) exposure.
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Interleukin-1beta (IL-1β): IL-1β is an early response pro-inflammatory cytokine with
many similar effects as TNF-α, such as recruitment and activation of inflammatory cells,
cell proliferation, extracellular matrix protein synthesis and induction of other proinflammatory cytokines. IL-1 secretion from AM’s has been shown to increase following
both in vivo and in vitro LPS exposures (Castranova et al., 2001), and following silica
exposure (Driscoll et al., 1990). Also, TII cells have been shown to increase their IL-1β
production following LPS (Haddad et al., 2002) or silica (Finkelstein et al., 1997)
exposure.
Interleukin-6 (IL-6): IL-6 is a pro-inflammatory cytokine associated with fibrogenic
activity (Lohmann-Matthes et al., 1994). IL-6 is produced by AM’s following in vivo
LPS exposure (Finkelstein et al., 1997). It is also produced by fetal alveolar TII cells
following LPS exposure (Haddad et al., 2002) and by hyperplastic TII cells in the fibrotic
human lung (Crestani et al., 1994). IL-6 synthesis can be mediated by other cytokines,
such as TNF-α and IL-1β (Kelley, 1990; Crestani et al., 1994).
Macrophage inflammatory protein-2 (MIP-2): MIP-2 is a pro-inflammatory cytokine with
chemotactic activity. It is involved in the recruitment of inflammatory cells (especially
PMN’s) to the site of tissue damage. MIP-2 also has a role in stimulating production of
other inflammatory mediators, such as IL-1β, TNF-α and histamine (Driscoll, 1994), and
it has been reported to enhance bacterial phagocytosis and killing by AM’s and PMN’s
(Standiford et al., 1996). MIP-2 secretion has been shown to increase in AM’s following
LPS (Shi et al., 1999) and silica (Driscoll et al., 1996 a; Barrett et al., 1999 b) exposures.
In addition, MIP-2 mRNA and protein increased in TII cells after LPS or silica exposures
in vivo and in vitro (Driscoll et al., 1996 a; Barrett et al., 1998 and 1999 a).
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Leukotrienes and prostaglandins: They are products of the breakdown of arachidonic acid
(cell membrane component) by lipoxygenase (LO) and cyclo-oxygenase (CO) enzymes,
respectively. Leukotrienes and prostaglandins are associated with increased
inflammation, including chemotaxis and inflammatory cytokine production (Dubois et
al., 1989). They have been shown to be released from AM’s and macrophage cell lines
upon both LPS and silica exposures (Dubois et al., 1989; Lohmann-Matthes et al., 1994;
Chen et al., 1995).
Although there has been some studies looking at mediator release from AM’s, TII and
RLE-6TN cells individually upon LPS and silica exposures (Bissonnette et al., 1990,
McRitchie et al., 2000 and Driscoll et al., 1996 a), there have been no studies, as far as
we know, comparing the responses of the 3 cell types side-by-side, and only few studies
looking at the interaction between primary AM’s and primary TII cells in a co-culture
system.
Importance of AM/TII intercellular interaction: Many studies have reported different
results between in vitro and in vivo settings. For instance, Huffman et al. (1998) saw an
increase in NO. released from AM’s following an in vivo silica exposure but could not
detect this increase upon exposing AM’s to silica in vitro. Also, conditioned medium
from BAL fluid (which includes mediators released from other alveolar cells including
TII cells and polymorphonuclear leukocytes (PMN’s)) following in vivo silica exposure
was effective in making naïve AM’s responsive to silica exposure in vitro. Hence, it is
clear that intercellular interactions play a major role in cellular responses, such as NO.
production. Many more studies contribute to the evidence of the importance of AM/TII
intercellular interactions. Those include a study by Miles et al. (1999) that has shown
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that surfactant (released from TII cells) inhibits LPS-induced NO. production from
AM’s. And along the same lines, Rao et al. (2000) have reported that surfactant
decreases LPS-induced TNF-α and IL-1β release from AM’s. In addition, Blau et al.
(1994) have shown that SP-A, an important surfactant protein, increases the production of
colony stimulating factor (CSF) from primary AM’s in vitro. Also, Leslie et al. (1985)
have reported that AM’s stimulate DNA synthesis in TII cells in vitro, and Standiford et
al. (1990) have shown that conditioned media from LPS-stimulated AM’s increased IL-8
mRNA in a human pulmonary TII-like epithelial cell line (A549). One more study that
stresses the importance of intercellular interactions in cellular responses is by Crestani et
al. (1994) who have shown that AM-conditioned media increases IL-6 production by TII
in vitro under basal conditions.
As discussed above, evidence suggests that hyperproduction of reactive oxidants and
inflammatory mediators plays a role in adverse pulmonary responses to silica or LPS. It
is also clear that AM’s and TII cells are involved in the production of these reactive and
inflammatory products. However, no data were found that compared the release of
several inflammatory mediators from AM’s and TII cells under the same culture
conditions, same exposures, and same cell concentrations. Also, no literature was found
that compared the responsiveness of a type II cell line to primary TII cells under the same
culture conditions and following exposure to LPS and silica. In addition, although
AM/TII cell interactions have been suggested to be very important in cellular responses,
this interaction has not been studied in parallel under different interaction conditions
(transwell and mixed co-culture) or different exposure conditions (basally, upon LPS
exposure, or following silica exposure). And finally, there haven’t been any studies that

13

attempted different approaches to try to find specific mediators important in AM/TII
intercellular communication.
Thus, the following questions remain unresolved:
1) What is the relative contribution of AM’s and TII cells to the production of oxidants,
chemokines, and cytokines in the lungs in response to LPS and silica? The answer to this
question could help in revealing which cell type contributes more inflammatory
mediators following lung injury caused by LPS or silica. It could also help reveal which
agent is more potent at stimulating inflammatory mediators release and hence inducing
more severe lung injury.
2) Is the responsiveness of RLE-6TN cell lines and primary TII cells similar? The answer
to this question could determine if RLE-6TN cell line could be used in research in place
of primary TII cells (since the TII isolation technique consumes animals, material, and
time and is thus costly).
3) Does intercellular communication between AM’s and TII cells alter the activity of
AM’s and/or TII cells? If so, what mediator(s) is/are involved in this intercellular
communication? The answer to this question could help in designing in vitro experiments
which more closely mimic in vivo situations.
To address these questions, this dissertation has the following objective and aims.
Main objective: Contribute to advancing the understanding of the role of AM’s and TII
cells in the induction of pulmonary inflammation and injury in response to silica and
LPS, and improve our understanding of the interaction between AM’s and TII cells which
would occur in vivo.
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Aim 1: Determine the relative responsiveness of AM’s, primary TII cells and RLE-6TN,
a TII cell line to silica and LPS under comparable conditions.
Aim 2: Determine if intercellular interactions exist and under what conditions they can be
demonstrated.
Aim 3: Attempt to identify the mediator(s) responsible for this interaction.
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Materials and Methods
Animal Model: All primary cells were collected from naive male Sprague-Dawley rats
250-300 g in weight (Hilltop Laboratory Animals, Scottsdale, PA). The animals were
housed at the National Institute for Occupational Safety and Health animal facility, which
is approved by AAALAC. Rats were housed under temperature and humidity controlled
conditions under a 12 hour light/12 hour dark cycle and were allowed a week of
acclimation before use in any experiment. They had free access to food and water at all
times.
AM Isolation by BAL: Rats were anesthetized intraperitoneally with sodium
pentobarbital (65 mg/kg body weight). The abdomen was cut vertically, the intestines
pushed aside, and the renal artery cut to exsanguinate the animals. The diaphragm was
carefully pierced to allow intrathoracic massaging of the lungs during the lavage
procedure. The trachea was then exposed and a tiny whole was cut in it to allow an 18
gauge needle coated with plastic tubing (inside diameter = 0. 040’’) to be inserted inside,
after which the trachea was tied with surgical thread to prevent any movement of the
needle during the lavage procedure. While massaging the lungs, a solution of ice-cold
calcium and magnesium-free phosphate buffered saline (PBS, 1x, 150 mM NaCl, 1. 9
mM KH2PO4, 9. 35 mM Na2PO4, pH 7. 3-7. 5) was repetitively introduced and sucked
back out of the lungs through a 10 ml syringe attached to the tracheal canula. The first
lavage consisted of only 2 ml/100g body weight to allow any trapped air in the lungs to
escape and prevent overinflation of the lungs. Subsequent lavage volumes were 8 ml
each, and the total volume of BAL fluid collected during this procedure was
approximately 80 ml. This fluid was then centrifuged at 1000g for 10 minutes, and after
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discarding the supernatant, the pellet was resuspended in 1 ml HAM’s F-12 medium (pH
7. 07-7. 40)supplemented with 1mM glutamine, 100 U/ml of penicillin-streptomycin, and
10% FBS.
AM’s were counted using an electronic cell counter (Coulter Multisizer II, Coulter
Electronics, Hialeah, FL) equipped with a 256 channel cell sizer that counts cells
according to their diameter. AM’s were identified as having a diameter of 9-18µm
(Castranova et al., 1990). The AM yield was 12 ± 4 million cells/rat (Figure 1: Coulter
tracing), the purity obtained by BAL was 90-98 % as verified microscopically (Porter et
al., 2002). Cell viability measured by LDH release, trypan blue exclusion and total
protein (TPRO) was 89 ± 5 % (see methods below).
TII Isolation and Purification by Panning: TII isolation was performed according to
Jones et al. (1982). Rats were anesthetized intraperitoneally with sodium pentobarbital
(65 mg/kg body weight). The abdomen was cut vertically, the intestines pushed aside,
and the renal artery cut to exsanguinate the animals. The diaphragm was carefully
pierced to deflate the lungs, and the chest cavity was cut open along the midrib line. The
heart and lungs were removed en bloc after cutting the trachea above the lungs and the
esophagus below the lungs. The lungs were perfused by instilling approximately 20 ml
of calcium and magnesium-free PBS through the right ventricle (thin-walled) into the
pulmonary artery. Perfusion was completed by instilling approximately 10 ml of the PBS
solution through the left ventricle (thick-walled) into each of the pulmonary veins until
the lungs were white. Next, an 18 gauge needle coated with plastic tubing (inside
diameter = 0. 040’’) was inserted in the trachea. The canula was tied with surgical thread
to prevent any movement of the needle during the procedure. While the lungs are being
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massaged, a solution of ice-cold EGTA (0. 2 mM) in PBS was repetitively introduced and
sucked back out of the lungs through a 10 ml syringe attached to the canula. The first
lavage consisted of only 2 ml/100g body weight to allow any trapped air in the lungs to
escape and prevent overinflation of the lungs. Subsequent lavage volumes were 8 mls
each, and the total volume of BAL fluid collected during this procedure was
approximately 50 ml. This fluid, which consisted mainly of AM’s, was then discarded.
The lungs were subsequently twice lavaged with 8 ml of a digestion solution consisting
of 40 U/ml type I porcine elastase, twice crystallized (ICN Biomedicals Inc., Aurora,
OH) and 0. 018% DNase from bovine pancreas (USB Corporation, Cleveland, OH) in
PBS. The rinsed lung was then filled with digestion solution and left to digest for a total
of 30 minutes in a 37º C water bath. Following digestion, the trachea and the main
bronchi were dissected away and discarded. The lungs were chopped with a tissue
chopper set at a cut thickness of 0. 5 mm. Digestion was then stopped by suspending the
minced lung tissue in an elastase inhibitor solution (25% FBS and 0. 018% DNase in
PBS), and the resultant suspension was successively filtered through 3 nylon mesh sheets
of smaller pore sizes (150, 330, and 440 mesh/cm2, New York Stencil, New York, NY).
The filtrate was centrifuged at 1000g for 10 minutes. The pellet containing unpurified
TII cells was then resuspended in 1 ml PBS. The cells were then counted and added to
the panning plate for TII purification. The panning plate was prepared according to
Dobbs et al. (1986) whereby a 100 mm tissue culture dish was coated with
approximately 2 mg of rat IgG ( Sigma, St Louis, MO) in 4 ml TRIS-base (50mM, pH 9.
5) for 3 hours at room temperature. After this coating period the IgG-treated plate was
washed 5 times with 10 ml PBS, and 1 time with 10 ml culture medium (HAM’s F-12
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medium supplemented with 1mM glutamine, 100 U/ml of penicillin-streptomycin, and
10% FBS).
The cells were added at a concentration of 20-30 million cells/10 ml culture medium/
IgG-coated culture dish, and incubated for 1 hour at 37ºC, after which the plate was
gently rocked and the supernatant which contained the purified TII cells (unlike
phagocytes, TII cells are a lung cell type that does not have Fc receptors for IgG and thus
would not adhere to the IgG coated plate) was collected and centrifuged. The pellet
obtained from the centrifugation was resuspended in 1ml culture medium, and the cells
were counted using an electronic cell counter (Coulter Multisizer II, Coulter Electronics,
Hialeah, FL) equipped with a 256 channel cell sizer that counts cells according to their
size. TII cells were identified as having a diameter of 7−12µm (Jones et al., 1982), the
yield was 25 " 8 million cells/rat (Figure2: Coulter tracing) and the viability was 89. 6 ±
2. 4%. TII cells were incubated overnight before using them in any exposure in order to
let them recover from the isolation procedure.
TII Identification and Purity Measurements:
Fluorescent microscopy:TII cells were identified by fluorescent microscopy upon
phosphine 3R (Roboz Surgical Instrument, Washington, DC) staining whereby the
lipophylic dye concentrates in the lamellar bodies which store the surfactant to give a
yellow-green fluorescence (Mason and Williams, 1976). Phosphine 3R solution in PBS
was added to the TII cell suspension at a final concentration of 0. 002%. Two minutes
later, the stained cells were viewed under a fluorescent microscope (Olympus AX70
photomicroscope equipped with a Sony 3CCD color video camera DXC 9000) at an
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absorption peak of 477 nm and an emission peak of 512 nm (Jones et al., 1982).
Phosphine 3R staining of the isolated TII cell preparation is shown in figure 3.
Transmission electron microscopy:TEM was also used to identify TII and estimate their
purity. In TEM, the cells were pelleted and fixed overnight in Karnovsky’s fixative (2.
5% gluteraldehyde and 3% paraformaldehyde in 0. 1 M sodium cacodylic buffer pH 7.
4). The pellet was post-fixed in 1% osmium tetroxide for 60 minutes, rinsed and placed
in 1% tannic acid (pH 7. 0) for 60 minutes, and rinsed and placed in 0. 5% uranyl acetate
for 45 minutes, all in a 8% sucrose and 0. 9% sodium chloride solution. The sample was
then dehydrated in an ethanol series and embedded in epon (LX,112, Ladd). The blocks
were thin sectioned on a Leica Ultracut and stained with 4% uranyl acetate for 15
minutes and Reynolds lead citrate for 20 minutes. The sections were viewed on a JOEL
1220 TEM at 80 kev. TII cells were identified as having lamellar bodies with swirls of
surfactant inside. TII cell purity was 91±5% (Fig 4, 5).
Rat lung epithelial-T-antigen negative, or RLE-6TN cells were derived from alveolar TII
cells by Kevin Driscoll et al. (1995a). Like primary TII cells, RLE-6TN cells contain
lamellar bodies for surfactant storage, and they have the ability to produce cytokines, NO.
and other ROS when stimulated (Stringer and Kobzik, 1998 and Driscoll et al., 2001).
Unlike primary TII cells, RLE-6TN cells maintain their morphology and the ability to
produce surfactant even after a long time in culture (few days). RLE-6TN cells were
obtained commercially (American type culture collection, Manassas, VA).
Cell Viability Measurements:
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Cell viability and number were monitored during cell culture to assure that cell
treatments did not cause excessive cellular toxicity or decrease the number of cells
surviving in culture.
Lactate dehydrogenase (LDH) activity: LDH was used as an indicator of cell cytotoxicity
as this enzyme which is usually in the cell cytoplasm can leak into the medium upon
membrane injury and disruption. To measure LDH activity, the exposure plates were
spun at 1000g for 10 minutes after which the supernatant was collected and part of it was
used for LDH measurement. A Cobas Mira Plus analyzer (Roche Diagnostics Systems,
Branchburg, NJ) was used to measure LDH release based on the increase in absorbance
at 340 nm during the oxidation of lactate to pyruvate, a reaction catalyzed by LDH.
Viability was determined as LDH released into the supernatant under control and test
conditions compared to LDH released by the same concentration of lysed cells.
Total cellular protein (TPRO): TPRO was used as an indicator of number of cells
attached to the culture plate. To measure TPRO, cells were sonicated using a Branson
Sonifier 450 (VWR Scientific, Columbus, OH) for 30 seconds at a duty cycle of 30% and
an output control of 3, and then centrifuged for 10 minutes at 1000g. TPRO was
measured from the supernatant using a Cobas Mira Plus analyzer (Roche Diagnostics
Systems, Branchburg, NJ) based on a colorimetric reaction (absorbance maximum at 540
nm).
Trypan blue exclusion: Trypan blue (Sigma, St Louis, MO) dye exclusion technique was
used as an indicator of cell cytotoxicity (Miles et al., 1988); since the dye can only enter
the cell when membrane integrity is lost. Trypan blue solution was added to the cell
culture wells at a final concentration of 0. 04%. After 4 minutes on ice, the cells were
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fixed with 10% formalin and observed under a light microscope. The percentage of cells
excluding dye was taken as the percent viability.
O2 consumption: Mitochondrial function measured by O2 consumption was also an
indicator of cell viability and cellular function. To measure oxygen consumption, a
Gilson 5/6 oxygraph (Gilson Medical electronics, Middleton, WI), equilibrated with a
Clark electrode was used. A baseline was established before adding 3x106 cells in 1. 5 ml
of calcium and magnesium supplemented (1 mM each) PBS into a preheated 37º C
chamber equipped with a stirrer. O2 consumed by the cells was measured over 10
minutes using a standard curve constructed by equilibrating the Clark electrode with
solutions bubbled with gases of various O2 concentrations.
Cell Culture: Cell culture medium used for all cell types was HAM’s F-12 medium
(Biowhittaker, Walkersville, MD) supplemented with 1mM glutamine, 100 U/ml of
penicillin-streptomycin, and 10% FBS. For RLE-6TN, the culture medium was
supplemented with pituitary extract (bovine, 10µg/ml) (Sigma, St Louis, MO), insulin
(bovine, 5µg/ml) (Sigma, St Louis, MO), IGF-1(human, recombinant,2. 5 ng/ml)
(Boehringer Mannheim, Indiannapolis, IN) and holo-transferrin (bovine, 25µg/ml)
(Sigma, St Louis, MO).
All exposures were done in vitro using 12-well culture plates (Fisher, Pittsburgh, PA).
Silica exposures used Min-U-Sil 5 (99% of silica particles<5µm in diameter; purity=98.
5% crystalline silica) obtained from U. S. Silica Corporation (Berkeley Springs, WV), at
concentrations 0-100µg/ml for 18 hour exposures, and 0-600µg/ml for 30 minute
exposures. LPS (Sigma, St Louis, MI) exposures were at concentrations of 0-10 µg/ml
for AM’s and TII cells’ 18 hour exposures, and 0-100µg/ml for RLE-6TN cells’ 18 hour
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exposures. LPS exposure concentrations for the three cell types for all 30 minute
exposures were 0-600µg/ml. When added to the culture, the TNF-α (Biosource,
Camarillo,CA), IL-1β (Biosource, Camarillo,CA), prostaglandin E2 (PGE2) and
leukotriene B4 (LTB4) (Sigma, St Louis, MO) final concentration used was 50ng/ml, and
H2O2 (Sigma, St Louis, MO) was added at a final concentration of 50µM. The tissue
culture plates were centrifuged following exposures at 1000g for 10 minutes before
collecting the medium. While some of the post-exposure medium was used right away
for LDH and TPRO measurement, the rest of it was stored in a -70º C freezer for future
TNF-α, MIP-2, IL-1β, IL-6 and NO. measurement. As for the cells attached to the
bottom of the wells, they were used to measure cellular viability. In all experiments,
exposure time for NO. , TNF-α, MIP-2, IL-1β and IL-6 studies was 18 hours. Exposure
time for ROS and O2- studies was 30 minutes. All exposures were performed in a 37 ºC
10% CO2 incubator.
Co-culture Systems:
Mixed co-culture: In a 12-well plate, TII and AM cells were cultured in the same well at
a concentration of 0. 25x106 cells/ml for each cell type. Silica exposures used Min-U-Sil
5 (silica particles<5µm) obtained from U. S. Silica Corporation (Berkeley Springs, WV),
at a final concentration of 100µg/ml for 18 hour exposures. LPS (Sigma, St Louis, MI)
exposures were at a final concentration of 10 µg/ml. When fibrinogen (Sigma, St Louis,
MO) was used to inhibit surfactant, it was initially dissolved in warm saline and then
added to the co-culture at a final concentration of 0. 8 mg/ml. All exposures were
performed in a 37 ºC 10% CO2 incubator. Figure 6 shows a micrograph of the cells in the
mixed co-culture plate showing close contact.
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Transwell co-culture: In a 12-well plate, AM and TII cells were separated by 0. 4µm pore
size inserts (Fisher, Pittsburgh, PA) which are placed in the main wells. While TII cells
were on the bottom of the plate submerged in a total volume of 1500 µl (medium plus or
minus stimulant plus or minus inhibitor). AM’s were lying on the insert surface
submerged in a total volume of 500 µl (medium plus or minus stimulant plus or minus
inhibitor). Figure 7 is a diagram of a 12-well plate transwell with dimensions. Either one
of the compartments can be exposed to the stimulant or just PBS. Cell concentration
used for both cell types was 0. 25x106 cells/ml. Exposure time for LDH, NO. , and
cytokines measurement was 18 hours. Fluid from both compartments was pooled after
exposure to measure cell mediators. Inhibitors were dissolved in PBS prior to their
addition into the co-culture medium with different final concentrations used for different
inhibitors. N-acetyl cysteine (NAC) (Sigma, St Louis, MO) was used as a non-specific
antioxidant at 1 mM; vitamin C(Sigma, St Louis, MO) was used as another non-specific
antioxidant at 250 µM; superoxide dismutase (SOD) (Sigma, St Louis, MO) was used as
a superoxide inhibitor at 250 U/ml; catalase (Sigma, St Louis, MO) was used as a
hydrogen peroxide inhibitor at 5000 U/ml; nordihydroguaiaretic acid (NDGA) (Sigma St
Louis, MO) was used as a lipooxygenase inhibitor at 1 µM; indomethacin (Sigma St
Louis, MO) was used as a cyclooxygenase inhibitor at 1 µM; anti-TNF-α (R&D systems,
Minneapolis, MN) was used as a TNF-α neutralizing antibody at 0. 5 µg/ml; and anti-IL1β (R&D, Minneapolis, MN) was used as an IL-1β neutralizing antibody at 0. 2 µg/ml.
Exposure time for NO. , TNF-α, MIP-2, IL-1β and IL-6 measurement was 18 hours. All
exposures were performed in a 37 ºC 10% CO2 incubator.
Conditioned medium cell culture:
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In a 12-well plate, AM and TII cells were cultured separately and without any exposure at
a concentration of 0. 25x106 cells/ml. TII-conditioned culture medium and AMconditioned culture medium were respectively transferred to AM’s and TII cells 18 hours
later.
Superoxide Anion (O2- .) Measurement by Cytochrome C Reduction:
Measurment of O2-. release using cytochrome C spectrophotometry relies on the change
in absorbance of cytochrome C (550nm) following its reduction by O2-. (Miles et al.,
1978). Cytochrome C (Sigma, St Louis, MO) dissolved in Hepes-buffered medium
(10mM Hepes, 145 mM NaCl, 5 mM KCl, 1mM CaCl2 and 5. 5 mM D-glucose; pH=7.
4) was added to all wells at a final concentration of 0. 12mM. 2x106 cells / ml in 96-well
microplates were exposed to 0-600 µg/ml LPS or 0-600µg/ml silica for 30 minutes at
37ºC. Cytochrome C reduction was measured before and after exposure using a
SpectraMax 250 spectrophotometer. Conversion from ∆OD units to O2-. concentration
was performed using the following formula: CL= ∆OD/e where C is the O2.
concentration expressed in mM, L is the path length in cm, ∆OD is the change in
cytochrome C absorbance and e is the O2-. extinction coefficient of 18. 7 mM-1cm-1 .
ROS Measurement:
Luminol-dependent chemiluminescence(CL): Measurment of ROS using luminol (5amino-2,3-dihydro-1,4-phthalazinedion)-amplified chemiluminescence relies on the
oxidation of luminol by H2O2/peroxidase system to form a luminol radical that produces
chemiluminescence (Li et al., 1999). A 22mM luminol stock solution was made by
dissolving 4 mg luminol (Sigma, St Louis, MO) in 100µl DMSO and then adding 900µl
of Hepes-buffered medium to the DMSO-dissolved luminol. The 96-well plate with a
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cell concentration of 2x106 cells/ml in Hepes-buffered medium (10mM Hepes, 145 mM
NaCl, 5 mM KCl, 1mM CaCl2 and 5. 5 mM D-glucose; pH=7. 4) was placed in the 37ºC
preheated measurement chamber where 1mM luminol (final concentration) was added to
each well at time 0. PBS, LPS (0-600µg/ml) or silica (0-600µg/ml) were then injected
into specified wells, and ROS measured for 30 minutes with emission at 460 nm on the
LB96P microplate luminometer. Chemiluminescence (CL) was expressed as relative
light units (RLU) per 2x106 cells per 30 minutes.
Confocal microscopy: Two different fluorescent dyes were used to microscopically detect
ROS; Dichlorodihydrofluorescein (DCFH), or dihydroethydium. To prepare the stained
cell slides, 0. 1-1x106 cells were placed in 24-well plates with coverslips (pretreated with
serum) inside the wells. Two hours later, the wells with cells inside were gently washed
with warm (37ºC) glucose solution (5mM glucose in PBS), and either DCFH (dissolved
in 5mM glucose solution and added at a final concentration of 25 µM) or
dihydroethydium (dissolved in 5mM glucose solution and added at a final concentration
of 10µM) dye was added in the dark. The cells were then exposed to PBS, LPS (0600µg/ml) or silica (0-600µg/ml) for 30 minutes in a 37 ºC 10% CO2 incubator, and
subsequently gently washed with the same glucose solution used earlier. The cells were
then fixed with 10% phosphate-buffered formalin solution for 10 minutes, after which the
wells were gently washed once with PBS and the coverslips placed on glass slides and
left to dry overnight. To view the stained cells, an LSM 510 Axiovert 200M confocal
microscope (Carl Zeiss, Inc., Thornwood, NY) was used; DCFH dye gave off green
fluorescence at 488nm when it reacted with released ROS, whereas dihydroethydium
gave off red fluorescence at 543 nm upon its reaction with ROS.
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NO. Measurement: Frozen post-exposure supernatants were thawed and used for NO.
measurement. Since NO. is a very unstable gas, the only way to chemically measure its
release is by measuring its oxidation products, nitrate (NO3) and nitrite (NO2),
collectively referred to as total NO. . A total NO. assay kit obtained from Assay
Designs, Inc (Ann Arbor, MI) was used to measure NO. in 96-well microplates. The kit
included a nitrate reductase to convert NO3 to NO2. It also included Greiss reagents that
interact with NO2 in a colorimetric reaction the products of which absorb light at 540nm.
A series of NO2 standards were run in parallel with the samples, and this standard curve
was used to convert light absorbance units into NO. concentrations. A SpectraMax 250
spectrophotometer was used to read the microplate absorbances and convert them to total
NO. concentrations.
Cytokine Measurement: Frozen post-exposure supernatants were thawed and used for
cytokine measurements. TNF-α, MIP-2, IL-1β and IL-6 cytokine concentrations were
measured using cytokine-specific ELISA (enzyme-linked immunosorbent assay) kits
obtained from Biosource International (Camarillo, CA). The kits included 96-well
microtiter plates with cytokine-specific antibody coated wells. The assay involved a
sandwich ELISA where cytokines in the samples attach to their specific antibody in the
well and are detected colorimetrically upon binding to another added antibody. A series
of cytokine standards were run in parallel with the samples, and this standard curve was
used to convert light absorbances into cytokine concentrations. A SpectraMax 250
spectrophotometer was used to read the microplate absorbances and convert them to
cytokine concentrations.
Diffusion Through the Transwell:
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To measure how well mediators and surfactant can cross the transwell insert, TNFα (5ng/ml) (Sigma, St Louis,MO) and artificial surfactant, Survanta (2mg/ml) (Abbott
Laboratories, Columbus, OH) were added to the bottom of the well, and they were
measured 18 hours later both from the bottom of the well and from the insert.
Surfactant Phospholipids Measured by Phosphorus Content:
Tissue culture medium phospholipid was measured according to Porter et al. (2001).
Briefly, 0. 5 ml fluid sample was mixed with 10 ml CHCl3: MeOH (2:1, v/v) followed by
incubation for 1. 5 hours at room temperature to extract the lipid. A 2 ml aliquot of icecold 0. 1 M KCl was then added, and the samples were mixed by inversion and then
centrifuged for 5 minutes at 2500 rpm. The top layer was then aspirated away and the
bottom layer washed 3 times by addition and aspiration of CHCl3: MeOH:H2O (3:48:47,
v/v/v), then dried. . The samples were then heated overnight at 150-160º C after addition
of 0. 5 ml of water and 0. 5 ml of 10 N H2SO4. A100 µl aliquot of 30% H2O2 were then
added to the samples before they were heated for another 1. 5 hours. Inorganic phosphate
was determined colorimetrically at 830 nm using a UV-2401 spectrophotometer
(Shimadzu; Columbia, MD), and a series of phosphate standards were run in parallel to
the samples.
Statistics: All data are means ± SEM of at least 3 trials. A Student “t” test was used for
mean comparison. p < 0.05 was considered statistically significant.
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Figure 1: Coulter tracing for AM’s ( diameter 9-18 µm). AM’s were isolated by BAL of
rat lungs. Particles smaller than 9µm on this graph are mostly debris.
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Figure 2: Coulter tracing for TII cells (7-12 µm in diameter) isolated by elastase
digestion of the lung and purified by differential adherence to IgG-coated surface. TII,
being a lung cell type not possessing Fc receptors for IgG, are purified in the supernatant
after adherence of the other cells. a- Before adherence; b- After adherence

a

b

Particle diameter (µm)
yield in (b)= 23.38x106cells/ml
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Figure 3A: Fluorescent microscopy of TII cells stained with phosphine 3R. The
globular inclusions emitting fluorescence are the lamellar bodies which contain
surfactant and concentrate the lipophylic dye. 3B: Focusing on a single TII cell
staining positively with phosphine 3R

A

B

10 µm
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Figure 4: TEM of a TII cell (x22,000). The stained swirls consist of phospholipids
surfactant in the lamellar bodies.
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Figure 5: TEM of a cell sample following TII isolation and purification by adherance.
TII cells are identified by swirls of surfactant inside them. Marked cells are TII.
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Figure 6: Micrograph of AM and TII cells in mixed co-culture. 0. 5x106 AM’s and 0.
5x106 TII cells are co-cultured together in a 12-well tissue culture plate in a total volume
of 2ml. Note how the cells are in close contact.
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Figure 7: A 12-well plate transwell with dimensions. AM’s (0. 25x106 cells/ml) were
placed in the insert, while 0. 5x106 TII cells were in the bottom of the well. The media
from both compartments were in contact. The transwell insert has a pore size of 0.4 µm.

12 mm
12 mm
Insert diameter: 12 mm
AM
TII
Well diameter: 24 mm
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Results
Objective: To advance the understanding of the role of AM and TII in the induction of
pulmonary inflammation and injury in response to silica and LPS.
Aim 1: Determine the relative responsiveness of AM, primary TII and a TII cell line to
silica and LPS under comparable conditions by comparing the mediator release by
primary rat AM’s, primary rat TII, and a rat TII cell line (RLE-6TN) upon stimulation
with LPS or silica.
Results for aim 1:
Cell cytotoxicity following LPS and silica exposures: Cell cytotoxicity was measured to
check for any cell death that might have been caused by LPS or silica exposure, and the
number of cells was measured to check if the cell concentration remained constant
throughout the 18 hour exposure period.
LPS did not cause substantial cytotoxicity or cell disintegration at the doses used in these
cultures over the 18-hour exposure period in AM’s (Table 1 and Figure 8), TII cells
(Table 2 and Figure 9), or RLE-6TN cells (Table 3 and Figure 10). Also, silica did not
cause substantial cytotoxicity or cell disintegration below 50µg/ml in AM’s (Table 4 and
Figure 11), TII cells (Table 5 and Figure 12), or RLE-6TN cells (Table 6 and Figure 13).
However, some cytotoxicity was noted at the 100µg/ml silica exposure for some assays.
NO. release upon LPS and silica exposure: LPS dose-responsively increased NO.
production from the three cell types (Figure 14). Primary AM’s produced considerably
more NO. in response to LPS than primary TII cells, which in turn were more active than
RLE-6TN cells in response to LPS exposure. Silica exposure in vitro did not result in
any detectable NO. production from the 3 cell types. In contrast, silica is a potent
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inducer of NO. production from BAL cells after in vivo exposure, and a potent inducer of
iNOS in AM’s and TII cells (Porter et al., 2002 b). Huffman and colleagues have shown
that silica induction of iNOS in AM’s requires communication between different types of
alveolar cells (Huffman et al., 1998). Such cross-talk is absent in this in vitro study.
TNF-α release upon LPS and silica exposure: Both LPS and silica dose-responsively
increased TNF-α production from primary AM’s and primary TII cells, but not from
RLE-6TN cells (Figures 15 and 16). Also, primary AM’s were more responsive to both
LPS and silica in TNF-α release than primary TII cells, which in turn were more active
than RLE-6TN cells. LPS induced far greater production of TNF-α from AM’s and
primary TII cells than silica did.
MIP-2 release upon LPS and silica exposure: Both LPS and silica dose-responsively
increased MIP-2 production from primary AM’s, primary TII and RLE-6TN cells
(Figures 17 and 18). Primary AM’s were more active in inducing MIP-2 release than
primary TII cells, which in turn were more active than RLE-6TN cells. LPS induced far
greater production of MIP-2 from the 3 cell types than silica did.
IL-1β release upon LPS and silica exposure: LPS and silica dose-responsively increased
IL-1β production from primary AM’s and primary TII cells, but not from RLE-6TN cells
(Figures 19 and 20). Primary AM’s were more active in inducing IL-1β release than
primary TII cells, which in turn were more active than RLE-6TN cells. Unlike the
production of NO. , TNF-α and MIP-2 where LPS was more potent than silica, both
agents induced comparable production of IL-1β from the 3 cell types.
IL-6 release upon LPS and silica exposure: LPS and silica dose-responsively increased
IL-6 production from primary AM’s, primary TII and RLE-6TN cells (Figures 21and 22).
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Upon LPS exposure, the 3 cell types had somewhat comparable abilities to produce IL-6,
although RLE-6TN cells were not responsive to low (< 0. 1 µg/ml) concentrations of
LPS. Upon silica exposure, primary AM’s were less active in inducing IL-6 release than
primary TII cells, which in turn were less active than RLE-6TN cells. LPS induced a
greater production of IL-6 from the 3 cell types than silica did.
O2- release with LPS and silica exposure: Silica dose-responsively increased O2production from primary AM’s, primary TII and RLE-6TN cells (figures 23, 24 and 25).
Upon silica exposure, primary AM’s and TII cells had comparable ability to produce O2-,
and that was greater than RLE-6TN ability. Silica induced a greater production of O2from the 3 cell types than did LPS, since no O2- release from the 3 cell types was noted
with LPS exposure.
ROS release with LPS and silica exposure: LPS dose-responsively increased ROS
production from primary AM’s measured externally as CL and internally with ROSsensitive dyes (figures 26 and 27). However, LPS failed to stimulate ROS from primary
TII or RLE-6TN cells. Silica dose-responsively increased ROS production from primary
AM’s (figures 28 and 29) and TII cells (figures 30 and 31), but not from RLE-6TN.
Upon silica exposure, AM’s and TII cells had comparable abilities to produce ROS.
Silica induced a greater production of ROS from AM’s and TII cells than LPS did since
LPS didn’t induce any detectable ROS in TII.
Aim 2: Determine if intercellular interactions exist and under what conditions they can
be demonstrated by evaluating the effect of rat AM mediator release on the physiological
functions of primary rat alveolar TII cells and visa versa under basal conditions, or upon
LPS or silica exposure. For this step, 2 types of co-culture systems were developed, a
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transwell co-culture system and a mixed co-culture system. Also, to evaluate the role of
surfactant in AM/TII interaction, fibrinogen, a surfactant inhibitor (Seeger et al., 1993;
Gupta et al., 2000), was added in some mixed co-culture experiments.
Results for aim 2:
TNF-α release in the co-culture systems: Figure 32 shows that in the transwell co-culture
system, there was considerable potentiation of TNF-α release compared to the sum of
mediator release from the 2 cell types cultured separately under basal conditions. Similar
potentiation was also observed upon silica exposure. Upon LPS stimulation, transwell
co-culture of the 2 cell types resulted in simply an additive (no interaction) TNF-α
release. In the mixed co-culture system, the potentiation seen under basal conditions and
upon silica exposure was removed, and there was an inhibition upon LPS stimulation of
the mixed co-culture system compared to the sum of TNF-α productions by AM and TII
cells cultured separately. Miles et al. (1999) have reported that surfactant can inhibit
LPS-induced NO. production by AM’s. We have shown that in the mixed co-culture
system AM’s and TII cells are in close contact (Figure 6). Therefore, we speculated that
TII cells could release surfactant which would down regulate cytokine production by
AM’s. This inhibiton might not be seen in the transwell system where AM’s and TII
cells are separated by a considerable distance. To test this hypothesis, the effects of
fibrinogen, a surfactant inhibitor, were monitored for AM plus TII in mixed culture under
basal conditions. Upon adding fibrinogen, the potentiation of TNF-α release in the
mixed co-culture system was significantly increased, i. e., the inhibitory effect of close
cell contact was removed (Figure 33).
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MIP-2 release in the co-culture systems: As Figure 34 shows, in the transwell co-culture
system, MIP-2 release was considerably potentiated compared to the sum of mediator
release from the 2 cell types cultured separately under basal conditions and upon silica
exposure. Upon LPS stimulation, the 2 cell types did not alter each others’ MIP-2
release, i. e., the MIP-2 release was additive. In the mixed co-culture system, the
potentiation seen under basal conditions and upon silica exposure was removed, and there
was an inhibition upon LPS stimulation of the mixed co-culture system compared to the
sum of MIP-2 release from AM’s and TII cells cultured separately. Upon adding
fibrinogen, the inhibition of MIP-2 release in the mixed co-culture system under
unstimulated conditions was significantly reversed, i. e., potentiation of basal MIP-2
release was observed in the mixed co-culture upon treatment with fibrinogen (Figure 35).
NO . release in the co-culture systems: In the transwell co-culture system, NO.
production was considerably potentiated compared to the sum of mediator release from
the 2 cell types cultured separately under basal conditions. Upon LPS or silica
stimulation, the 2 cell types did not alter each others’ NO. release, i. e., additive NO.
production was seen. In the mixed co-culture system, the potentiation seen in the
transwell system under basal conditions was reversed into an inhibiton, and there was an
inhibition upon LPS and silica stimulation of the mixed co-culture system below the
additive production (Figure 36). Upon adding fibrinogen, the inhibition of NO. release
by the mixed co-culture system under unstimulated conditions was significantly
attenuated (Figure 37).
IL-1β release in the co-culture systems: In the transwell co-culture system: no significant
potentiation of IL-1β release was noted compared to the sum of mediator release from the
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2 cell types cultured separately under basal conditions or upon LPS stimulation. Upon
silica exposure, considerable potentiation of IL-1β release was seen. In the mixed coculture system, there was no change in the basal IL-1β release compared to the transwell
co-culture system. However, the potentiation seen upon silica exposure was removed,
and there was an inhibition upon LPS stimulation of the mixed co-culture system (Figure
38).
Upon adding fibrinogen to the mixed co-culture system under basal conditions, there was
a significant increase in IL-1β release compared to the mixed cells with no fibrinogen
under unstimulated conditions; i. e., potentiation became evident (Figure 39).
IL-6 release in the co-culture system: In the transwell co-culture system, considerable
potentiation of IL-6 release was noted compared to the sum of mediator release from the
2 cell types cultured separately under basal conditions and upon LPS and silica
stimulation. In the mixed co-culture system, there was no change in the IL-6 release
compared to the transwell co-culture system under unstimulated conditions, but the
potentiation seen upon LPS or silica exposure was removed (Figure 40). Upon adding
fibrinogen to the mixed culture system, there was no change in IL-6 release compared to
the mixed cells with no fibrinogen under basal conditions (Figure 41).
Filter effect on AM’s: The question arised as to whether the filter of the transwell insert
itself could have a stimulatory effect on AM’s. TNF-α and MIP-2 were measured from
0. 25x106 AM’s grown for 18 hours either on a plate or in the transwell insert. Figure 42
shows that in fact the filter has a slight inhibitory effect on AM’s. Therefore, the
potentiation of mediator release observed under transwell co-culture conditions cannot be
accounted for by the filter effect.
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Mediators and surfactant diffusion through the transwell filter: TNF-α (5ng/ml) or
Survanta (2mg/ml) were placed in the bottom compartment of the transwell and they
were measured 18 hours later in both the bottom compartment and the insert to check if
they diffused freely through the insert or if they were blocked partially or totally by the
filter. Figure 43A shows that TNF-α levels were not significantly different in the
separate compartments, and thus TNF-α can freely diffuse through the transwell filter.
As for Survanta, according to Figure 43 B, only about 20% diffused from the plate
bottom into the insert through the transwell, which means that the transwell filter
significantly inhibits surfactant diffusion between the two compartements.
Fibrinogen as a surfactant inhibitor: Unlike the situation for AM’s, surfactant does not
inhibit LPS-stimulated mediator production by RAW cells (Rao et al., FASEB J. 1999).
Therefore, RAW cells were mixed co-cultured with TII cells in the presence or absence
of fibrinogen, and TNF-α and MIP-2 were measured in both cases (Figure 44). No
change in the TII/RAW co-culture response was observed with or without fibrinogen,
which suggests that the increase in AM/TII mixed co-culture potentiation upon adding
fibrinogen was not a nonspecific fibrinogen effect.
Aim 3: Attempt to identify the mediator(s) responsible for the AM/TII intercellular
interaction by trying to identify which mediator(s) contribute significantly to the
interaction of AM’s and TII cells in a transwell system under basal conditions. For this
step, different mediator inhibitors were added to unstimulated transwell co-culture plates.
N-acetyl cysteine (NAC) (Sigma, St Louis, MO) was used as a non-specific antioxidant
at 1 mM; vitamin C (Sigma, St Louis, MO) was used as another non-specific antioxidant
at 250 µM; superoxide dismutase (SOD) (Sigma, St Louis, MO) was used as a
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superoxide inhibitor at 250 U/ml; catalase (Sigma, St Louis, MO) was used as a hydrogen
peroxide inhibitor at 5000 U/ml; nordihydroguaiaretic acid (NDGA) (Sigma St Louis,
MO) was used as a lipooxygenase inhibitor at 1 µM; indomethacin (Sigma St Louis, MO)
was used as a cyclooxygenase inhibitor at 1 µM; anti-TNF-α (R&D systems,
Minneapolis, MN) was used as a TNF-α neutralizing antibody at 0. 5 µg/ml; and anti-IL1β (R&D, Minneapolis, MN) was used as an IL-1β neutralizing antibody at 0. 2 µg/ml.
Results for Aim 3:
Results from addition of inhibitors: No cytotoxicity was noted upon addition of any
inhibitor in the study. However, all inhibitors used significantly decreased TNF-α
potentiation in AM/TII transwell co-cultures under basal conditions (Figures 45 A); also,
all inhibitors except anti-IL-1β significantly decreased MIP-2 potentiation (Figures 45
B). These results suggest that oxidants, lipooxygenase and cyclooxygenase products
(leukotrienes and prostaglandins), TNF-α, and IL-1β could all be involved in AM/TII
intercellular communication.
Results from addition of mediators: In addition to adding inhibitors to attempt to identify
mediator(s) that contribute to the interaction of AM and TII cells in a transwell system
under basal conditions, different mediators and/or their combinations were added to
either AM or TII cultures. Mediators added were hydrogen peroxide (H2O2) (50 µM)
which is an oxidant product, TNF-α protein used at 50 ng/ml, IL-1β protein used at 50
ng/ml, prostaglandin E2 (PGE2) at 50 ng/ml which is a product of cyclooxygenase, and
leukotriene B4 (LTB4) (50 ng/ml) which is a lipooxygenase product.
None of the mediators or their combinations caused cytotoxicity in AM’s or TII cells.
However, in general addition of mediators to AM or TII cultures did not affect release of
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TNF-α or MIP-2 (Figures 46 A, 47 A and 47 B). The only exception was a significant
stimulatory action of TNF-α on MIP-2 production by AM’s (Figure 46 B). Addition of
other mediators in combination to TNF-α to AM’s did not augment the stimulatory effect
of TNF-α alone (Figure 48).
Conditioned media results: A third way of trying to identify mediators for the AM/TII
communication was to expose AM’s to TII-conditioned medium or expose TII cells to
AM-conditioned medium. AM’s cultured in TII-conditioned medium did not release
more TNF-α or MIP-2 than control AM’s (Figure 49). However, TII cells cultured in an
18-hour AM-conditioned medium released significantly more TNF-α and MIP-2 than
control TII cells (Figure 50). These results suggest that some mediator(s) released from
AM’s basally is/are able to potentiate TII basal response. To check if this/these
mediators include TNF-α or IL-1β, an anti-TNF-α or anti-IL-1β neutralizing antibody
was added to the TII culture when adding the 18-hour AM-conditioned medium to it.
Neither the anti-TNF-α nor the anti-IL-1β decreased the potentiation conferred to TII
cells by adding the AM-conditioned medium to them (Figures 51 A and B). These results
suggest that neither TNF-α nor IL-1β is a main mediator released from AM’s basally
which potentiates TII cells.
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Table 1: LPS-induced cytotoxicity in primary rat AM’s measured by LDH release into
the medium and the percentage of cell nuclei stained with trypan blue. 106 cells/ml were
exposed to increasing LPS concentrations for 18 hours. Values are presented as change
from control (means ± SE of 5 experiments). Note that the total LDH release for 1x106
sonicated AM’s ~ 115 U/L.

LPS Dose (µg/ml)

Exposure-Induced
LDH Release (U/L)

0

0±0

Exposure-Induced
Cell Nuclei with
Trypan Blue (%)
0. 0 ± 0. 0

0. 025

6. 8 ± 5. 6

1. 8 ± 1. 2

0. 05

5. 8 ± 5. 8

3. 5 ± 2. 2

0. 1

1. 6 ± 1. 6

1. 3 ± 1. 3

1

2. 4 ± 2. 4

2. 8 ± 2. 4

5

5. 2 ± 3. 6

2. 0 ± 1. 2
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Figure 8: TPRO from primary rat AM’s upon LPS exposure. 106 cells/ml were exposed
to increasing LPS concentrations for 18 hours. Values are means ± SE of 4 experiments.
Note that TPRO is an indicator of cell number.
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Table 2: LPS-induced cytotoxicity in primary rat TII cells measured by LDH release into
the medium and the percentage of cell nuclei stained with trypan blue. 106 cells/ml were
exposed to increasing LPS concentrations for 18 hours. Values are presented as change
from control (means ± SE of 4 experiments). Note that the total LDH release for 1x106
sonicated TII cells ~ 170 U/L.

LPS Dose (µg/ml)

Exposure-Induced
LDH Release(U/L)

0

0±0

Exposure-Induced
Cell Nuclei with
Trypan Blue (%)
0. 0 ± 0. 0

0. 025

0±0

0. 75 ± 0. 75

0. 05

0±0

3. 25 ± 1. 89

0. 1

0±0

1. 0 ± 1. 0

1

0. 75 ± 0. 75

2. 25 ± 1. 65

5

0. 75 ± 0. 48

2. 75 ± 1. 89
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Figure 9: TPRO from primary rat TII cells upon LPS exposure. 106 cells /ml were
exposed to increasing LPS concentrations for 18 hours. Values are means± SE of 4
experiments. Note that TPRO is an indicator of cell number.
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Table 3: LPS-induced cytotoxicity in RLE-6TN cells measured by LDH release into the
medium and the percentage of cell nuclei stained with trypan blue. 106 cells/ml were
exposed to increasing LPS concentrations for 18 hours. Values are presented as change
from control (means ± SE of 4 experiments). Note that the total LDH release for 1x106
sonicated RLE-6TN ~ 505 U/L.

LPS Dose (µg/ml)

Exposure-Induced
LDH Release (U/L)

0

0±0

Exposure-Induced
Cell Nuclei with
Trypan Blue (%)
0. 0 ± 0. 0

10

3. 5 ± 2. 6

1. 4 ± 1. 4

25

13. 8 ± 3. 8

3. 6 ± 2. 54

50

6. 5 ± 4. 3

1. 0 ± 1. 0

75

2±2

0. 40 ± 0. 40

100

3±3

1. 6 ± 1. 6
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Figure 10: TPRO from RLE-6TN cells upon LPS exposure. 106 cells/ml were exposed
to increasing LPS concentrations for 18 hours. Values are means ± SE of 4 experiments.
Note that TPRO is an indicator of cell number.
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Table 4: Silica-induced cytotoxicity in primary rat AM’s measured by LDH release into
the medium and the percentage of cell nuclei with trypan blue. 106 cells /ml were
exposed to increasing silica concentrations for 18 hours. Values are presented as change
from control (means ± SE of 4 experiments). Note that the total LDH release for 1x106
sonicated AM’s ~ 115 U/L.

Silica Dose (µg/ml)

Exposure-Induced
LDH Release (U/L)

0

0. 0 ± 0. 0

Exposure-Induced
Cell Nuclei with
Trypan Blue (%)
0. 0 ± 0. 0

5

16. 7 ± 13. 3

0. 75 ± 0. 75

25

11. 0 ± 6. 6

3. 0 ± 1. 78

50

27. 0 ± 12

5. 25 ± 2. 56

100

52. 0 ± 4. 8

6. 5 ± 2. 72
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Figure 11: TPRO from primary rat AM’s upon silica exposure. 106 cells/ml were
exposed to increasing silica concentrations for 18 hours. Values are means ± SE of 4
experiments. Note that TPRO is an indicator of cell number.
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Table 5: Silica-induced cytotoxicity in primary rat TII cells measured by LDH release
into the medium and the percentage of cell nuclei stained with trypan blue. 106 cells/ml
were exposed to increasing silica concentrations for 18 hours. Values are presented as
change from control (means ± SE of 4 experiments). Note that the total LDH release for
1x106 sonicated TII cells ~ 170 U/L.

Silica Dose (µg/ml)

Exposure-Induced
LDH Release(U/L)

0

0. 0 ± 0. 0

Exposure-Induced
Cell Nuclei with
Trypan Blue (%)
0. 0 ± 0. 0

5

0. 0 ± 0. 0

0. 75 ± 0. 75

25

0. 25 ± 0. 25

3. 0 ± 1. 78

50

1. 0 ± 0. 71

5. 25 ± 2. 56

100

13. 5 ± 5. 78

6. 5 ± 2. 72
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Figure 12: TPRO from primary rat TII cells upon silica exposure. 106 cells/ml were
exposed to increasing silica concentrations for 18 hours. Values are means ± SE of 4
experiments. Note that TPRO is an indicator of cell number.
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Table 6: Silica-induced cytotoxicity in RLE-6TN cells measured by LDH release into the
medium and the percentage of cell nuclei stained with trypan blue. 106 cells/ml were
exposed to increasing silica concentrations for 18 hours. Values are presented as change
from control (means ± SE of 4 experiments). Note that the total LDH release for 1x106
sonicated RLE-6TN ~ 505 U/L.

Silica Dose (µg/ml)

Exposure-Induced
LDH Release(U/L)

0

0. 0 ± 0. 0

Exposure-Induced
Cell Nuclei with
Trypan Blue (%)
0. 0 ± 0. 0

5

13. 0 ± 13. 0

3. 4 ± 1. 5

20

24. 5 ± 24. 5

2. 8 ± 1. 8

50

46. 8 ± 46. 8

3. 8 ± 2. 0

100

84. 3 ± 28. 6

7. 4 ± 1. 6
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Figure 13: TPRO from RLE-6TN cells upon silica exposure. 106 cells/ml were exposed
to increasing silica concentrations for 18 hours. Values are means ± SE of 4 experiments.
Note that TPRO is an indicator of cell number.
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Figure 14: Exposure- induced NO. release from the 3 cell types upon LPS exposure.
1x106 cells /ml were exposed to increasing concentrations of LPS for 18 hours. Values
are means ± SE of 4 experiments. Note the break in the x-axis. * indicates a significant
difference (p<0. 05) from control (0 LPS) for each cell type.
200

*

*

Primary AM
Primary TII
RLE-6TN

175
150

NO(uM)

125
100

*

75
50

*

*
*

25

*

*

*

*

0
0

1

2

3

4

5 10 20 30 40 50 60 70 80 90 100

LPS(µg/ml)

57

Figure 15: Exposure- induced TNF-α release from the 3 rat alveolar cell types upon LPS
exposure. 1x106 cells/ml were exposed to increasing concentrations of LPS for 18 hours.
There was no detectable TNF-α release from RLE-6TN cells upon LPS exposure.
Values are means ± SE of 4 experiments. Note the breaks in the axes. * indicates a
significant difference (p<0. 05) from control (0 LPS) for AM’s and TII cells.
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Figure 16: Exposure- induced TNF-α release from the 3 rat alveolar cell types upon
silica exposure. 1x106 cells/ml were exposed to increasing concentrations of silica for 18
hours. There was no detectable TNF-α release from RLE-6TN cells upon silica
exposure. Values are means ± SE of 4 experiments. * indicates a significant difference
(p<0. 05) from control (0 silica) for AM’s and TII cells.
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Figure 17: Exposure- induced MIP-2 release from the 3 rat alveolar cell types upon LPS
exposure. 1x106 cells/ml were exposed to increasing concentrations of LPS for 18 hours.
Values are means ± SE of 3 experiments. Note the breaks in the axes. * indicates a
significant difference (p<0. 05) from control (0 LPS) for each cell type.
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Figure 18: Exposure- induced MIP-2 release from the 3 rat alveolar cell types upon silica
exposure. 1x106 cells/ml were exposed to increasing concentrations of silica for 18
hours. Values are means ± SE of 4 experiments. Note the break in the y-axis. *
indicates a significant difference (p<0. 05) from control (0 silica) for each cell type.
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Figure 19: Exposure- induced IL-1β release from the 3 rat alveolar cell types upon LPS
exposure. 1x106 cells/ml were exposed to increasing concentrations of LPS for 18 hours.
There was no detectable IL-1β release from RLE-6TN cells upon LPS exposure. Values
are means ± SE of 4 experiments. Note the break in the x-axis. * indicates a significant
difference (p<0. 05) from control (0 LPS) for AM’s and TII cells.
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Figure 20: Exposure- induced IL-1β release from the 3 rat alveolar cell types upon silica
exposure. 1x106 cells/ml were exposed to increasing concentrations of silica for 18
hours. There was no detectable IL-1β release from RLE-6TN cells upon silica exposure.
Values are means ± SE of 4 experiments. * indicates a significant difference (p<0. 05)
from control (0 silica) for AM’s and TII cells.
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Figure 21: Exposure- induced IL-6 release from the 3 rat alveolar cell types upon LPS
exposure. 1x106 cells/ml were exposed to increasing concentrations of LPS for 18 hours.
Values are means ± SE of 3 experiments. Note the break in the x-axis. * indicates a
significant difference (p<0. 05) from control (0 LPS) for each cell type.
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Figure 22: Exposure- induced IL-6 release from the 3 rat alveolar cell types upon silica
exposure. 1x106 cells / ml were exposed to increasing concentrations of silica for 18
hours. Values are means ± SE of 4 experiments. Note the break in the x-axis. *
indicates a significant difference (p<0. 05) from control (0 silica) for each cell type.
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Figure 23: Exposure- induced O2- release (measured by cytochrome C reduction) from
AM’s upon silica exposure. 2x106 cells/ml were exposed to increasing concentrations of
silica for 30 minutes. Values are means ± SE of 4 experiments. * indicates a significant
difference (p<0. 05) from control (0 silica).
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Figure 24: Exposure- induced O2- release (measured by cytochrome C reduction) from
TII cells upon silica exposure. 2x106 cells/ml were exposed to increasing concentrations
of silica for 30 minutes. Values are means ± SE of 4 experiments. * indicates a
significant difference (p<0. 05) from control (0 silica).
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Figure 25: Exposure- induced O2- release (measured by cytochrome C reduction) from
RLE-6TN cells upon silica exposure. 2x106 cells/ml were exposed to increasing
concentrations of silica for 30 minutes. Values are means ± SE of 4 experiments. *
indicates a significant difference (p<0. 05) from control (0 silica).
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Figure 26: Exposure- induced ROS (measured by luminol-dependent
chemiluminescence) release from AM’s upon LPS exposure. 2x106 cells/ml were
exposed to increasing concentrations of LPS for 30 minutes. Values are means ± SE of 4
experiments. * indicates a significant difference (p<0. 05) from control (0 LPS).
Chemiluminescence: CL; Relative light units: RLU
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Figure 27: Confocal microscopy of AM’s with dihydroethydium dye (indicator of ROS)
upon LPS exposure. 2x106cells/ml were exposed to 600µg/ml LPS for 30 minutes.
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Figure 28: Exposure- induced ROS (measured by luminol-dependent
chemiluminescence) release from the AM’s upon silica exposure. 2x106 cells/ml were
exposed to increasing concentrations of silica for 30 minutes. Values are means ± SE of
7 experiments. * indicates a significant difference (p<0. 05) from control (0 silica).
Chemiluminescence: CL; Relative light units: RLU
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Figure 29 : Confocal microscopy of AM’s with dihydroethydium dye (indicator of
ROS) upon silica exposure. 2x106 cells/ml were exposed to 600µg/ml silica for 30
minutes.
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Figure 30: Exposure- induced ROS (measured by luminol-dependent
chemiluminescence) release from primary rat TII cells upon silica exposure. 2x106 cells /
ml were exposed to increasing concentrations of silica for 30 minutes. Values are means
± SE of 4 experiments. * indicates a significant difference (p<0. 05) from control (0
silica).
Chemiluminescence: CL; Relative light units: RLU
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Figure 31: Confocal microscopy of primary rat TII cells with dihydroethydium dye
(indicator of ROS) upon silica exposure. 2x106 cells/ml were exposed to 600µg/ml silica
for 30 minutes.
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Figure 32: TNF-α release in mixed AM/TII co-culture, transwell AM/TII co-culture, or
AM and TII monocultures. AM and primary TII cell concentration used in all cases was
0. 25x106 cells/ml, exposure time was 18 hours. Values are means ± SE of 4
experiments. * indicates a significant difference (p<0. 05) between AM/TII transwell
co-culture and the sum of the separate cultures(AM+TII). + indicates a significant
difference (p<0. 05) between mixed and transwell co-cultures.
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Figure 33: TNF-α potentiation (value in the mixed co-culture system minus value of the
sum of the separate cell cultures) upon adding 0. 8mg/ml fibrinogen (a surfactant
inhibitor) to AM/TII basal mixed co-culture versus TNF-α potentiation without adding
fibrinogen (control). AM and TII cell concentration used in all cases was 0. 25x106
cells/ml, exposure time was 18 hours. Values are means ± SE of 4 experiments. *
indicates a significant increase in the mediator potentiation upon adding fibrinogen.
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Figure 34: MIP-2 release in mixed AM/TII co-culture, transwell AM/TII co-culture, or
AM and TII monocultures. AM and TII cell concentration used in all cases was 0.
25x106 cells/ml, exposure time was 18 hours. Values are means ± SE of 4 experiments.
* indicates a significant difference (p<0. 05) between AM/TII transwell co-culture and
the sum of the separate cultures (AM+TII). + indicates a significant difference (p<0. 05)
between mixed and transwell co-cultures.
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Figure 35: MIP-2 potentiation (value in the mixed co-culture system minus value of the
sum of the separate cell cultures) upon adding 0. 8mg/ml fibrinogen (a surfactant
inhibitor) to AM/TII basal mixed co-culture versus MIP-2 potentiation without adding
fibrinogen (control). AM and TII cell concentration used in all cases was 0. 25x106
cells/ml, exposure time was 18 hours. Values are means ± SE of 4 experiments. *
indicates a significant increase in the mediator potentiation upon adding fibrinogen.
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Figure 36: NO. release in mixed AM/TII co-culture, transwell AM/TII co-culture, or
AM and TII monocultures. AM and TII cell concentration used in all cases was 0.
25x106 cells/ml, exposure time was 18 hours. Values are means ± SE of 4 experiments.
* indicates a significant difference (p<0. 05) between AM/TII transwell co-culture and
the sum of the separate cultures (AM+TII). + indicates a significant difference (p<0. 05)
between mixed and transwell co-cultures.
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Figure 37: NO. potentiation (value in the mixed co-culture system minus value of the
sum of the separate cell cultures) upon adding 0. 8mg/ml fibrinogen (a surfactant
inhibitor) to AM/TII basal mixed co-culture versus NO. potentiation without adding
fibrinogen (control). AM and TII cell concentration used in all cases was 0. 25x106
cells/ml, exposure time was 18 hours. Values are means ± SE of 4 experiments. *
indicates a significant reversal of mediator inhibition upon adding fibrinogen.
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Figure 38: IL-1β release in mixed AM/TII co-culture, transwell AM/TII co-culture, or
AM and TII monocultures. AM and TII cell concentration used in all cases was 0.
25x106 cells/ml; exposure time was 18 hours. Values are means ± SE of 4 experiments.
* indicates a significant difference (p<0. 05) between AM/TII transwell co-culture and
the sum of the separate cultures (AM+TII). + indicates a significant difference (p<0. 05)
between mixed and transwell co-cultures.
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Figure 39: IL-1β potentiation (value in the mixed co-culture system minus value of the
sum of the separate cell cultures) upon adding 0. 8mg/ml fibrinogen (a surfactant
inhibitor) to AM/TII basal mixed co-culture versus IL-1β potentiation without adding
fibrinogen (control). AM and TII cell concentration used in all cases was 0. 25x106
cells/ml, exposure time was 18 hours. Values are means ± SE of 4 experiments. *
indicates a significant increase in the mediator potentiation upon adding fibrinogen.
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Figure 40: IL-6 release in mixed AM/TII co-culture, transwell AM/TII co-culture, or
AM and TII monocultures. AM and TII cell concentration used in all cases was 0.
25x106 cells/ml; exposure time was 18 hours. Values are means ± SE of 4 experiments.
* indicates a significant difference (p<0. 05) between AM/TII transwell co-culture and
the sum of the separate cultures(AM+TII). + indicates a significant difference (p<0. 05)
between mixed and transwell co-cultures.
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Figure 41: IL-6 potentiation (value in the mixed co-culture system minus value of the
sum of the separate cell cultures) upon adding 0. 8mg/ml fibrinogen (a surfactant
inhibitor) to AM/TII basal mixed co-culture versus IL-6 potentiation without adding
fibrinogen (control). AM and TII cell concentration used in all cases was 0. 25x106
cells/ml, exposure time was 18 hours. Values are means ± SE of 4 experiments.
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Figure 42: TNF-α and MIP-2 levels from AM’s cultured on the transwell insert (or
filter) relative to AM’s cultured on the plate surface. AM concentration used in all cases
was 0. 25x106 cells/ml; exposure time was 18 hours. Values are means ± SE of 3
experiments.
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Figure 43 A: Diffusion of TNF-α through the transwell. (5 ng/ml) TNF-α was added to
the bottom transwell compartment (plate bottom), and 18 hours later, TNF-α was
measured in both the bottom compartment and the insert. Values are means ± SE of 3
experiments.
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Figure 43 B: Diffusion of Survanta through the transwell. 2 mg/ml Survanta was added
to the bottom transwell compartment (plate bottom), and 18 hours later, Survanta
phospholipid was measured in both the bottom compartment and the insert. Values are
means ± SE of 3 experiments. * indicates a significant difference (p<0. 05) in
phospholipid content between the transwell insert and the plate bottom.
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Figure 44: TNF-α and MIP-2 potentiation (value in the mixed co-culture system minus
value of the sum of the separate cell cultures) upon adding 0. 8mg/ml fibrinogen (a
surfactant inhibitor) to RAW/TII mixed co-culture versus potentiation without adding
fibrinogen (control). RAW and TII cell concentration used in all cases was 0. 25x106
cells/ml; exposure time was 18 hours. Values are means ± SE of 3 experiments.
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Figure 45 A: Fold difference (value in the transwell co-culture system divided by value
of the sum of the separate cell cultures) in TNF-α release upon adding different
inhibitors to AM/TII basal transwell co-culture versus fold difference without adding any
inhibitor (control). AM and TII cell concentration used in all cases was 0. 25x106
cells/ml; exposure time was 18 hours. * indicates a significant decrease (p<0. 05) in
potentiation upon adding the inhibitor versus control. Values are means ± SE of 5
experiments.
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Figure 45 B: Fold difference (value in the transwell co-culture system divided by value
of the sum of the separate cell cultures) in MIP-2 release upon adding different inhibitors
to AM/TII basal transwell co-culture versus fold difference without adding any inhibitor
(control). AM and TII cell concentration used in all cases was 0. 25x106 cells/ml;
exposure time was 18 hours. * indicates a significant decrease (p<0. 05) in potentiation
upon adding the inhibitor versus control. Values are means ± SE of 5 experiments.
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Figure 46 A: TNF-α levels relative to control upon adding different mediators to AM’s.
AM concentration used was 0. 25x106 cells/ml; exposure time was 18 hours. Values are
means ± SE of 6 experiments.
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Figure 46 B: MIP-2 levels relative to control upon adding different mediators to AM’s.
AM concentration used was 0. 25x106 cells/ml; exposure time was 18 hours. * indicates
a significant increase (p<0. 05) in MIP-2 release upon adding the mediator versus control.
Values are means ± SE of 6 experiments.
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Figure 47 A: TNF-α levels relative to control upon adding different mediators to TII
cells. TII concentration used was 0. 25x106 cells/ml; exposure time was 18 hours.
Values are means ± SE of 6 experiments.
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Figure 47 B: MIP-2 levels relative to control upon adding different mediators to TII
cells. TII concentration used was 0. 25x106 cells/ml; exposure time was 18 hours.
Values are means ± SE of 6 experiments.

MIP-2 levels / MIP-2(control)

2.5

2.0

1.5

1.0

0.5

0.0
control

+TNF-α

+H2O2

+IL-1β

+PGE2

Hydrogen peroxide (H2O2) (50 µM): oxidation product
TNF-α protein (50 ng/ml)
IL-1β protein (50 ng/ml)
Prostaglandin E2 (PGE2) (50 ng/ml): cyclooxygenase product
Leukotriene B4 (LTB4) (50 ng/ml): lipooxygenase product

94

+LTB4

Figure 48 : MIP-2 levels relative to control upon adding different mediator combinations
to AM’s. AM concentration used was 0. 25x106 cells/ml; exposure time was 18 hours. *
indicates a significant increase (p<0. 05) in MIP-2 release upon adding the mediator(s)
versus control. Values are means ± SE of 6 experiments.

3.5

MIP-2 levels / MIP-2 (control)

*
*

3.0
*
2.5

*

*

2.0

1.5

1.0

0.5

0.0
control

+TNF-α

+(T+I)

+(T+I+H) +(T+P+L) +(T+I+H+P+L)

(H): Hydrogen peroxide (50 µM): oxidation product
(TNF-a or T): TNF-α protein (50 ng/ml)
(I): IL-1β protein (50 ng/ml)
(P): Prostaglandin E2 (50 ng/ml): cyclooxygenase product
(L): Leukotriene B4 (50 ng/ml): lipooxygenase product

95

Figure 49: TNF-α and MIP-2 from AM’s cultured in normal medium (control) and from
AM’s cultured in an 18-hour TII-conditioned medium. AM and TII concentration used
was 0. 25x106 cells/ml; exposure time was 18 hours. Values are means ± SE of 3
experiments.
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Figure 50: TNF-α and MIP-2 from TII cells cultured in normal medium (control) and
from TII cells cultured in an 18-hour AM-conditioned medium. TII and AM
concentration used was 0. 25x106 cells/ml; exposure time was 18 hours. * indicates a
significant (p<0. 05) increase compared to control. Values are means ± SE of 3
experiments.
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Figure 51 A: MIP-2 from TII cells cultured in normal medium (control) and from TII
cells cultured in an 18-hour AM-conditioned medium, and in an 18-hour AM-conditioned
medium plus anti-TNF-α. TII and AM concentration used was 0. 25x106 cells/ml;
exposure time was 18 hours. * indicates a significant (p<0. 05) increase compared to
control. Values are means ± SE of 3 experiments.
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Figure 51 B: TNF-α and MIP-2 from TII cells cultured in normal medium (control) and
from TII cells cultured in an 18-hour AM-conditioned medium, and in an 18-hour AMconditioned medium plus anti-IL-1β. TII and AM concentration used was 0. 25x106
cells/ml; exposure time was 18 hours. * indicates a significant (p<0. 05) increase
compared to control. Values are means ± SE of 3 experiments.
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Discussion
AM’s are the alveolar derivatives of blood monocytes and are the first line of defense
against outside contaminants and invaders (Lohmann-Matthes et al., 1994).
Phagocytizing AM’s can produce reactive oxygen species through a respiratory or
oxidative burst that directly contributes to killing microorganisms (Johnson, 1978).
When incapable of killing foreign organisms by themselves, AM’s recruit more
phagocytic cells to the area by releasing chemokines, such as macrophage-inflammatory
protein-2 (MIP-2), which acts to attract polymorphonuclear leukocytes (PMN’s),
monocytes and other cells from the pulmonary capillaries to the alveolar airspaces
(Nielson et al., 1995). TII cells constitute approximately 60% of the alveolar epithelial
cell population in number (Crapo et al., 1983). They are known to synthesize, store and
secrete the surfactant material lining the alveoli. They can also produce NO., ROS and
cytokines in response to different stimuli (Punjabi et al., 1994). RLE-6TN cells were
derived from rat alveolar TII cells by Driscoll et al. (1995a). Like primary TII cells,
RLE-6TN cells contain lamellar bodies for surfactant storage, and they have the ability to
produce cytokines, NO. and other ROS when stimulated (Stringer and Kobzik, 1998;
Driscoll et al., 2001).
As discussed earlier, evidence suggests that hyperproduction of reactive oxidants and
inflammatory mediators plays a role in adverse pulmonary responses to silica or LPS. It
is also clear that AM’s and TII cells are involved in the production of these reactive and
inflammatory products. However, no data were found that compared the release of
several inflammatory mediators from AM’s and TII cells under the same culture
conditions, same exposures, and same cell concentrations. Also, no literature was found
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that compared the responsiveness of RLE-6TN, a type II cell line, to primary TII cells
under the same culture conditions and following exposure to LPS and silica. In addition,
although AM/TII cell interactions have been suggested to be very important in cellular
responses, this interaction has not been studied in parallel under different interaction
conditions (transwell and mixed co-culture) or different exposure conditions (basally,
upon LPS exposure, or following silica exposure). And finally, there haven’t been any
studies that attempted different approaches to try to find specific mediators important in
AM/TII intercellular communication.
Main objective of this study: Contribute to advancing the understanding of the role of
AM’s and TII cells in the induction of pulmonary inflammation and injury in response to
silica and LPS, and improve our understanding of the interaction between AM’s and TII
cells which would occur in vivo.
Aim 1: Determine the relative responsiveness of AM’s, primary TII cells and RLE-6TN,
a TII cell line to silica and LPS under comparable conditions. This part of the study was
an attempt to answer the following unresolved questions: 1) What is the relative
contribution of AM’s and TII cells to the production of oxidants, chemokines, and
cytokines in the lungs following LPS or silica exposure? The answer to this question
could help in revealing which cell type contributes more inflammatory mediators
following lung injury caused by LPS or silica. It could also help reveal which agent is
more potent at stimulating the release of inflammatory mediators and hence inducing
more severe lung injury. 2) Is the responsiveness of cell lines and primary cells similar?
The answer to this question could determine if RLE-6TN cell line could be used in
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research in place of primary TII cells, since TII isolation technique is more time and
money consuming.
Main results and discussion for aim 1:
1A-Responsiveness of cell types to stimuli:
AM>TII: (True for NO. ,TNF-α, MIP-2, and IL-1β, but not true for IL-6 and ROS):
The results of the present study show that primary AM’s were significantly more active
in producing NO., TNF-α, MIP-2, IL-1β, and ROS than primary TII cells, which in turn
were more active than RLE-6TN cells upon LPS exposure. Upon silica exposure,
primary AM’s are significantly more active in producing TNF-α, MIP-2, and IL-1β than
primary TII cells, which in turn are more active than RLE-6TN cells. In contrast,
primary AM’s and primary TII cells released equivalent amounts of IL-6, and ROS upon
exposure to silica.
AM’s, being professional phagocytes, can clear inhaled microbes and particles from the
lungs. Therefore, it’s expected that AM’s would secrete high levels of inflammatory
cytokines and reactive products which can cause lung damage and inflammation both of
which might play a critical role in occupational lung diseases. The data in the present
study support the major contribution of AM’s in lung inflammation and disease upon
occupational exposure, but it also raises another lung cell type to a higher importance
level as far as its contribution to pulmonary disease. Indeed, data from our results
suggest that, although AM’s are more active than TII cells in producing many
inflammatory mediators upon LPS and silica exposure, TII cells are also capable of
producing highly significant levels of inflammatory mediators. Indeed, our data support
recent evidence suggesting that alveolar type II epithelial cells (TII) may significantly
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contribute to lung inflammation by a direct interaction with a stimulant (Blau et al., 1994;
Crippen et al., 1995; Finkelstein et al., 1997). Our data also extend previous literature by
measuring mediator release from primary TII cell cultures instead of TII-like cell lines
used in most previous studies.
Among the very few studies comparing AM’s and TII cells in separate primary cultures
are those from Crestani et al. (1994), which support our findings that TII cells produce
more IL-6 than AM’s basally in vitro. Also, it’s not surprising to see that TII cells could
produce comparable amounts of ROS as AM’s upon silica exposure. Indeed, TII O2
consumption measured basally in the present study in preliminary studies characterizing
the viability of TII cells was approximately 193 ± 82nmoles/106cells/hr, and this value is
comparable to values reported in the literature (Jones et al., 1982), and is significantly
greater than AM oxygen consumption (~ 46. 2 nmoles/106cells/hr) as reported by
Castranova et al. (1980). TII cells are more dependent on mitochondrial respiration,
whereas AM’s are more dependent on glycolysis (Fisher et al., 1980). This is manifested
basally and upon exposure. Indeed, Chandel et al., (2000), reported that, while LPS
activates NF-κB in the murine macrophage cell line J 774. 1 through the release of
significant levels of ROS, mitochondrial ROS are not required for LPS activation of NF-

κB in J 774. 1. Previous data from Driscoll et al., (2001), have reported a significant
increase in mitochondrial-derived H2O2 in RLE-6TN cells following silica exposure. Our
data complement previous literature by having measured this ROS increase in primary
TII cells. TII have a higher intracellular taurine concentration, and a comparable
ascorbate intracellular concentration than AM’s (Banks et al., 1989; Castranova et al.,
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1983). Since TII cells contain more antioxidants than AM’s, they might have the ability
to produce more oxidants while resisting oxidant injury.
TII>RLE-6TN (True for NO. , TNF-α, MIP-2, IL-1β, and ROS ; but not true for IL-6):
When it was established, RLE-6TN cell line had promise to be a potential alternative to
the costy and time consuming TII cell isolation in studies involving pulmonary epithelial
cells (Driscoll et al., 1995a). Indeed, since then, the RLE-6TN cell line has been used in
place of primary TII cells in many experiments studying the pulmonary epithelium
without questioning its sensitivity or its level of responsiveness compared to primary TII
cells. For this reason, the present study had, among other aims, the goal to compare
primary rat TII cells to RLE-6TN cells, a rat TII cell line. For this purpose, the same
mediators released from the two cell types were measured under comparable conditions.
Primary TII cells were significantly more active in producing NO. , TNF-α, MIP-2, IL1β, and ROS than RLE-6TN cells upon LPS exposure. Upon silica exposure, primary
TII cells were significantly more active in producing TNF-α, MIP-2, IL-1β, and ROS
than RLE-6TN cells. In addition, primary TII cells showed a higher sensitivity to LPS
and silica than RLE-6TN. Indeed, a much higher LPS or silica dose is required to initiate
significant mediator release from RLE-6TN cells. For some mediators, namely TNF-α
and IL-1β, even very high stimulant doses, which caused some cell injury, were
incapable of inducing significant release from RLE-6TN cells. This lower
responsiveness and sensitivity of the TII cell line to stimuli was obvious in data by
Driscoll et al. (1996a) where it’s clear to see that induction of MIP-2 mRNA from
primary TII cells was more than MIP-2 mRNA from RLE following exposure to the same
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silica dose. Primary TII cells also responded at a lower silica dose and were thus more
sensitive than the cell line.
Some studies have reported similar responsiveness of primary TII and RLE-6TN cells to
certain stimuli. In fact, whereas our study reports a several fold lower sensitivity and
responsiveness for MIP-2 release from RLE-6TN compared to primary TII cells upon
LPS exposure, Driscoll et al. (1996a) showed that MIP-2 mRNA measured in both cell
types was similar following LPS exposure. After looking at Driscoll’s study
experimental procedures, it was noticed that this group’s TII cell isolation technique
involved culturing the cells for 3 days after isolation prior to exposure. Reports indicate
that morphological and biochemical changes in primary TII cells are more probable with
time in culture (Dobbs et al., 1986). This could explain the reason for the lower
responsiveness of primary TII cells in Driscoll’s study. Other studies reporting lower
primary TII cell responsiveness include one by Punjabi et al. (1994) where no significant
induction of NO. production was detected in primary TII cells in response to 1 µg/ml
LPS. Comparing the experimental conditions of the study by Punjabi and colleagues to
the study in our hands, one main difference could be observed. Indeed, we used 106
cells/well which is over three times more cells per well than Punjabi and colleagues’
study that only used 3 x 105 cells/well. It might be possible that NO. production from the
lower cell number could not be detected by the Greiss reaction technique.
Although using the RLE-6TN cell line would have been a less costly and time consuming
method to study pulmonary epithelial TII cells, our results suggest that using this cell line
would not reflect, or even be close to responses of primary TII cells. Hence, RLE-6TN
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cells may not be a good substitute for primary TII cells in separate culture or in co-culture
with other cell types.
1B- Potency of stimuli: As mentioned earlier, silica and LPS are two main airborne
contaminants of major importance to lung pathology. Silica, being highly fibrogenic and
biologically toxic, can directly cause cellular toxicity. It can also initiate an
inflammatory response that could include increased oxidant production and
proinflammatory mediator secretion as a result of nuclear transcription factor-κB (NF-

κB) activation (Kang et al., 2000; Vallyathan and Shi, 1997) in target and recruited cells.
Also, the cellular signaling cascade triggered by LPS binding to target cells is believed to
induce the synthesis and release of many inflammatory mediators, such as the proinflammatory cytokines TNF-α, IL-β, and IL-6, (Chen et al., 1995; Christman et al.,
1998).
In the present study, LPS was found to be more potent than silica in inducing NO., TNF-

α, MIP-2, and IL-6 release from the 3 cell types. In contrast, LPS and silica had a
comparable ability to induce IL-1β production from the 3 cell types, whereas silica was
more potent than LPS in inducing ROS production, especially from primary TII cells.
LPS>silica. (True for NO. , TNF-α, MIP-2 and IL-6; not true for IL-1β or ROS):
Although Chen et al. (1995) reported a stronger activation of one of the NF-κB forms
(p50/p50 homodimer) in the early phase after stimulation of a macrophage cell line with
silica than after stimulation with LPS, considerable literature supports the hypothesis that
LPS is more potent than silica in inducing cytokine release from AM’s. Blackford et al.,
(1994) have shown that iNOS mRNA and enzyme levels increase much more in AM’s
following in vivo exposure of rat to LPS (89 fold for the mRNA and 7 fold for the protein
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respectively) than following silica exposure (36 and 3 fold, respectively). Also, Dubois
et al. (1989) reported that TNF and LTB4 release from primary AM’s following in vitro
LPS exposure was higher than the released from AM’s following silica exposure. Much
less data exist that compare LPS and silica exposure in primary TII or RLE-6TN cells.
Some data from Driscoll et al. (1996a) suggest that MIP-2 mRNA from primary TII and
RLE-6TN cells following in vitro LPS exposure might be higher than that produced
following silica exposure. Our data clearly show that LPS is more potent than silica in
inducing NO. and MIP-2 from primary TII and RLE-6TN cells. Our data also show that
LPS is more potent than silica in inducing TNF-α from primary TII cells. As for ROS,
although silica and LPS have been both reported to induce ROS release in some TII cell
lines and AM’s (Barrett et al. (1999 a and b); Shi et al. (1999)), the relative potency of
these two stimuli was not directly compared. Chen et al. (1998) reported that the
antioxidant ascorbate decreased silica-induced, but not the LPS-induced, NF-κB
activation in the macrophage cell line RAW 264. 7, suggesting that ROS production was
greater after silica exposure than after LPS exposure. Also, Zeidler et al. (2003) has
reported slightly lower H2O2 levels in murine AM’s exposed in vitro to LPS than silica.
As for the present study, while the results for AM’s show that ROS released following in
vitro silica exposure are comparable or slightly higher than ROS levels released
following LPS exposure, results for primary TII cells show a much higher potency of
silica compared to LPS in inducing ROS. Indeed, whereas LPS produced no detectable
increase in oxidant release in primary TII cells, silica stimulated these cells to produce
high levels of ROS, which exceeded those produced by AM’s under the same exposure
conditions.
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As mentioned earlier and, as expected, silica exposure did not result in a substantial
release of NO. from our three cell types. Indeed, Huffman et al. (1998) have shown that
although in vivo exposure to silica can stimulate NO. production from various cell types,
it cannot do the same in vitro. Also, conditioned medium from BAL fluid (which
includes mediators released from TII cells) following in vivo silica exposure was
effective in making naïve AM’s produce NO. in response to silica exposure in vitro. The
most probable explanation for the contrasting results between the in vivo and in vitro
setting is the presence of multiple types of cells in the in vivo setting. Hence, different
cells in the lung alveolar area, including AM’s and TII cells or recruited PMN’s, might
interact with each other, thereby possibly modifying each other’s responses. Many more
studies contribute to the evidence of the importance of AM/TII intercellular interactions.
Those include a study by Miles et al. (1999) that has shown that surfactant released from
TII cells inhibits LPS-induced NO. production from AM’s in vitro. Along the same
lines, Rao et al. (2000) have reported that surfactant decreases LPS-induced TNF-α and
IL-1β release from AM’s in vitro. In contrast, Blau et al. (1994) have shown that SP-A,
an important surfactant protein, increases the production of colony stimulating factor
(CSF) from primary AM’s in vitro. Also, Leslie et al. (1985) have reported that AM’s
stimulate DNA synthesis in TII cells in vitro, while Standiford et al. (1990) have shown
that conditioned media from LPS-stimulated AM’s increased IL-8 mRNA in A549, a
human pulmonary TII-like epithelial cell line. One more study that stresses the
importance of intercellular interactions in cellular responses is by Crestani et al. (1994)
which showed that AM-conditioned media increases IL-6 production by TII in vitro
under basal conditions.
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Aim 2: Determine if intercellular interactions exist and under what conditions they can be
demonstrated. Does intercellular communication alter the activity of AM’s and/or TII
cells? The answer to this question could help in developing in vitro experiments to more
closely mimic in vivo situations. In this part of the study, AM/TII intercellular
communication was evaluated under two different co-culture settings: the cell types were
separated by a transwell insert, or they were mixed in culture.
Main results and discussion for aim 2:
2A-Transwell co-culture: In the transwell setting of the present study, AM’s probably do
not go across the insert filter since its 0. 4µm pore size is 5 times smaller than the 2µm
Boyden chamber membrane pore size used to measure chemotaxis (Schagat et al., 2003).
The most consistent change observed using this experimental system was considerable
potentiation under basal conditions, i. e., the co-culture release of mediators was
significantly above the sum of production by the cells cultured separately. Indeed, TII
and AM cells considerably potentiated each others’ NO., TNF-α, MIP-2, and IL-6
release. However, they did not alter each others’ IL-1β production. On the other hand,
stimulation of AM/TII transwell co-culture with LPS or silica resulted in an inconsistent
profile of responses, which generally consisted of less potentiation, especially upon LPS
exposure, compared to basal conditions. The results from the transwell co-culture system
can be summarized as follows:
Transwell basal significant potentiation. (True for NO., TNF-α, MIP-2 and IL6; not
true for IL-1β)
Transwell basal potentiation >Transwell LPS potentiation. (True for NO., TNF-α,
MIP-2 and IL-1β; not true for IL-6)
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Transwell silica potentiation >Transwell LPS potentiation. True for TNF-α, MIP-2
and IL-1β; not true for IL-6 and NO. )
Although TII/AM transwell potentiated basal NO. production, less potentiation was seen
for NO. production after silica exposure. Therefore, TII/AM interaction can not explain
the activation of silica induced NO. production in vivo or in vitro after exposure to BAL
fluid from silica-exposed rats (Huffman et al., 1998).
2B-Mixed co-culture: In the mixed co-culture system, there was a trend for less
potentiation or even significant inhibition of mediator release. TII and AM cells only
slightly potentiated each others’ TNF-α, IL-1β and IL-6 release. They did not alter each
others’ MIP-2. They inhibited each others’ NO. release.
To explain the above mentioned results, we theorized that surfactant released from TII
cells is inhibiting cytokine and oxidant release from AM’s whenever it’s able to reach
them. The ability of surfactant and other mediators, namely TNF-α, to diffuse through
the transwell was measured. The results showed that TNF-α was able to freely diffuse
across the transwell filter. However, free diffusion of surfactant was inhibited by
approximately 80% by the presence of the transwell filter between the bottom well and
the insert. Thus, when the 2 cell types are in direct contact as in the mixed co-culture
system, surfactant’s effects on AM’s are more apparent compared to when the cells are
separated by the transwell filter. Other investigators have supported this theory. Indeed,
Miles et al. (1999) has shown that surfactant inhibits AM responsiveness to LPS. Also,
for our theory to stand, it has to be clarified that TII cells are able to secrete surfactant in
culture and that AM’s are able to engulf all the released surfactant in our experimental
setting. Indeed, Mason et al. (1980) have shown that primary TII cells in culture are able
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to synthesize saturated phospatidylcholine and phosphatidylglycerol (lipid components in
surfactant) linearly for days in culture. Chander et al. (1983) have shown that 0. 25x106
primary TII cells in vitro can synthesize ~2.5 µg/ml DSPC during a 6-hour incubation
period, that would be equivalent to 7.5 µg/ml DSPC during 18 hours, which is the time
period of our exposure. In addition, Dobbs et al. (1987) have shown that ~2% of the
synthesized DSPC is secreted by 0. 25x106 primary TII cells in vitro every 6 hours. So 6
% would be secreted in 18 hours. 7. 5x6 /100 = 0. 45µg/ml DSPC is secreted in our
setting. Miles et al. (1988) have shown that 2.4 µg/ml DSPC, which would be much
greater than the 0. 45µg/ml DSPC secreted in our setting can be totally internalized in
vitro by an AM concentration equivalent to the one we used. Therefore, all the surfactant
secreted would be available to the AM’s to affect AM secretory activity (Miles et al.,
1999). In addition, the lower basal potentiation observed upon adding silica and LPS to
the AM/TII transwell co-culture could be explained by the fact that silica and LPS
(possibly more than silica) increase surfactant phospholipid release by alveolar TII cells
(Porter et al., 2001; Sugahara et al., 1996).
The alveolar lining in a rat lung has been reported to have an average thickness of ~ 0.2

µm (Bastacky et al., 1995). The portion of the AM volume in contact with surfactant in
vivo is not known and hence the inhibition of AM’s by surfactant might or might not be
significant in vivo. Therefore, the question of whether an in vitro transwell or mixed
AM/TII co-culture setting might more closely mimic the in vivo situation is still
unanswered.
To support our theory stating that surfactant is an inhibitory mediator released from TII
cells and acting on AM’s, a surfactant inhibitor, fibrinogen (Seeger et al., 1993; Gupta et
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al., 2000), was added in the mixed co-culture system. The results showed that the
inhibitory effect observed in the basal mixed co-culture system was removed for NO. ,
TNF-α, MIP-2, and IL-1β by inhibiting surfactant with fibrinogen. Preliminary control
studies indicate that fibrinogen did not stimulate AM’s or TII cells separately.
Mixed co-culture potentiation <Transwell co-culture potentiation. (True for NO.,
TNF-α and MIP-2; not true for IL-1β and IL-6)
Fibrinogen (surfactant inhibitor) decreased the mixed basal co-culture inhibition.
(True for NO., TNF-α, MIP-2 and IL-1β; not true for IL6)
The above results support the hypothesis that surfactant probably is the inhibitory
mediator released from TII cells which acts on AM’s, since inhibiting surfactant
decreased the significant inhibition in mediator release observed under basal conditions
in the AM/TII mixed co-culture compared to transwell co-culture. Therefore, it could be
argued that basal transwell co-culture conditions could prove to be very helpful in
studying surfactant effects on lung cells.
Whereas lung surfactant seems to have inhibitory effects on AM’s, adding Survanta to
lung fibroblasts might stimulate IL-6 mRNA production from these cells (personnel
communication with Dr Murali Rao). Knowing that surfactant could be in contact with
fibroblasts in the case where alveolar TI epithelial cells are damaged and/or dead,
cytokine release from AM/fibroblast intercellular interaction could be very important to
investigate.
AM/TII cell interaction could change with the type of cells used, i. e., primary vs. cell
line. For example, Tao and Kobzik (2002) reported different results than ours; i. e., they
reported an increase in TNF-α and MIP-2 in AM/RLE-6TN mixed co-culture but not in
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transwell co-culture exposed to silica. It could be argued that the contrasting results of
Tao and Kobzik (2002) can be explained by their using the RLE-6TN cell line instead of
primary TII cells. Indeed, Driscoll et al. (1995a) has shown that RLE-6TN cells produce
much less surfactant than primary TII cells. In addition, just like surfactant was reported
to differentially regulate chemotaxis of different neutrophil populations (Schagat et al.,
2003), it is possible that it interacts differently with different cell types. Indeed, using the
macrophage cell line RAW 264. 7 instead of primary AM’s resulted in significantly
different effects of surfactant on macrophage activity. Indeed, Rao et al. (1999) have
shown that Survanta does not inhibit LPS-induced NO. production in the macrophage
cell line RAW 264. 7, whereas it significantly inhibits NO. production by LPS-induced
primary AM’s (Miles et al., 1999). Rao et al. (2002) also showed that the signaling
pathways for NF-κB activation of various macrophage cell lines upon LPS exposure may
differ from primary AM’s, supporting that cell lines might not be a good model system.
The AM/TII cell interaction also changes with exposure. Indeed, LPS and silica
exposures could modify the levels and/or the functions of important mediators in
intercellular interactions. For example, LPS and silica increase surfactant levels
(Sugahara et al., 1996; Porter et al., 2001). LPS has also been reported to directly interact
with surfactant (Kalina et al., 1995; Kuau et al., 1992), which could possibly lead to
modification of surfactant functions.
Aim 3: An AM/TII intercellular communication was found to exist and to be
significantly highlighted under unstimulated transwell co-culture conditions. Therefore,
this part of the study was an attempt to answer the following question: what mediator(s)
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is/are involved in the AM/TII intercellular communication? The answer to this question
could help in designing in vitro experiments to be closer to in vivo situations.
Three experimental approaches were taken to try to determine possible intercellular
mediators. The first approach was to determine the effect of some inhibitors on the
AM/TII transwell basal interaction as far as cytokine release is concerned. The second
approach was to determine the effect of adding exogenous mediators to AM or TII cell
monocultures on the ability of the cell types to release cytokines, and the third approach
was to add unstimulated conditioned medium following an 18-hour culture from one cell
type onto the other and observe any alteration in cytokine release.
Main results and discussion for aim 3:
3A-Conditioned medium experiments
AM conditioned medium increased cytokine release (TNF-α and MIP-2) from TII
meaning that some mediator(s) from AM’s could be potentiating TII cell. Indeed, Leslie
et al. (1985) reached the same conclusion when AM conditioned medium stimulated
DNA synthesis in TII cells. Also, AM conditioned medium has been reported to increase
basal IL-6 release from primary TII cells (Crestani et al., 1994). To try to find out if
this/those mediators include TNF-α and/or IL-1β, antibodies for these mediators were
added to the AM conditioned medium before adding it to the TII culture. The results
were as follow:
Anti-TNF-α and anti-IL-1β didn’t decrease the TII potentiation induced by adding
the AM conditioned medium, suggesting that TNF-α and IL-1β might not be the main
mediators in the intercellular communication.
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TII conditioned medium didn’t increase TNF-α or MIP-2 release from AM’s,
suggesting that no mediator released from TII is influencing TNF-α or MIP-2 release
from AM’s.
3B-Mediator experiments (done on the AM’s or TII cells separately): Mediators used
were exogenous TNF-α, IL-1β, H2O2, PGE2 and LTB4
Hydrogen peroxide (H2O2): As mentioned earlier, H2O2 is an important ROS. When cells
like AM’s and TII respond to a stimulant, high levels of ROS can be generated that may
overwhelm the cells’ antioxidant capacity and cause oxidative stress. ROS can cause
direct cell damage by oxidizing lipids (Dalal et al., 1990), proteins, carbohydrates, and
DNA which confer to ROS a microbicidal and tumoricidal role (Johnston, 1978). They
can also cause indirect cell and /or tissue damage by inducing cellular production of other
pro-inflammatory mediators, such as TNF-α, MIP-2, IL-1β, IL-6 and other mediators
regulated by NF-κB and AP-1 nuclear transcription factors (Comhair and Erzurum,
2002). In the present study, exogenous H2O2 (Shi et al., 1999), was added to the culture
medium of separate cell types in order to assess role of oxidants on each cell type and
thus see if oxidants are potential mediators in AM/TII cell interaction.
Tumor necrosis factor-alpha (TNF-α): TNF-α is a very important inflammatory cytokine
synthesized as an early response mediator in cellular stimulation (Martin, 1999). It’s a
mediator in the recruitment and activation of inflammatory cells, cell proliferation, and
extracellular matrix protein synthesis (Driscoll, 1996 b). It can stimulate the production
of other pro-inflammatory cytokines, such as MIP-2 (Driscoll et al., 1996 a; Barrett et al.,
1999 a) and IL-6 (Crestani et al., 1994), and oxidant species, such as ROS and NO. ,
through the activation of NF-κB (Driscoll et al., 2001; Barrett et al., 1999 a), and/or other
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cellular components. In our study, exogenous TNF-α protein (Crestani et al., 1994), was
added to the culture medium of separate cell types (AM’s or TII cells) in order to assess
its role on each cell type and thus see if it could be a mediator in the AM/TII cell
interaction.
Interleukin-1beta (IL-1β): IL-1β is an early response pro-inflammatory cytokine with
many similar effects as TNF-α, such as recruitment and activation of inflammatory cells,
cell proliferation, extracellular matrix protein synthesis and induction of other proinflammatory cytokines. In the present study, exogenous IL-1β protein (Crestani et al.,
1994), was added to the culture medium of separate cell types (AM’s or TII cells) in
order to assess its role on each cell type and thus see if it could be a mediator in the
AM/TII cell interaction.
Leukotrienes and prostaglandins: They are products of the breakdown of arachidonic acid
(a cell membrane component) by lipoxygenase (LO) and cyclo-oxygenase (CO) enzymes,
respectively. Leukotrienes and prostaglandins are generally associated with increased
inflammation, including chemotaxis and inflammatory cytokine production (Dubois et
al., 1989). In the our study, exogenous LTB4 or PGE2 (Christman et al., 1991), were
added to the culture medium of separate cell types (AM’s or TII cells) in order to assess
their role on each cell type and see if either one could be a mediator in the AM/TII cell
interaction.
Out of all the exogenous mediators added to separate AM or TII cell cultures, only
TNF-α added to AM’s stimulated cytokine release (MIP-2). These results show that
TNF-α is a stimulant for AM’s. But since the TII conditioned medium on AM’s results
suggested that MIP-2 does not increase in AM’s following the addition of TII
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conditioned medium, it could be argued that TNF-α level released from TII cells is not
enough to potentiate MIP-2 release from AM’s, and that maybe an additional source of
TNF-α is needed for AM MIP-2 potentiation in vivo. As for the effect of exogenous
TNF-α on TII cells, although our results suggest that this mediator does not potentiate
MIP-2 release from TII cells, a study by Koyama et al. (1999) that measured different
end points following TNF-α addition to a TII-like cell line (A549) found significant
stimulation. Indeed, Koyama et al. have reported an increase in monocyte
chemoattractant protein-1 (MCP-1) and LTB4 from A549 following TNF-α addition. In
addition, whereas use of exogenous H2O2 in our study did not induce an increase in TNF-

α or MIP-2 from AM’s or TII cells (cultured separately), Shi et al. (1999) have reported
that H2O2 induced an increase in MIP-2 mRNA from an NR 8383 rat AM cell line. The
discrepancy of the above results could be explained by the fact that Shi et al. (1999) have
used a cell line instead of primary AM’s, which could very well have different responses
than primary cells, as was demonstrated earlier. As for the results in the present study
showing that exogenous IL-1β did not stimulate TNF-α or MIP-2 release from AM’s or
from TII cells, these data certainly do not mean that IL-1β does not stimulate AM’s or
TII cells in general. Indeed, Standiford et al. (1990) have measured different end points
upon adding exogenous IL-1β and found significant stimulation such as an increase in
IL-8 from an A549 TII-like cell line. Furthermore, Punjabi et al. (1994) reported an
induction of NO. release in TII cells, and Yang et al. (1999) showed an increase in TII
DNA synthesis following IL-1β addition. Finally, although our data with mediator
addition report no stimulation of TNF-α or MIP-2 release from AM’s or TII cells upon
PGE2 or LTB4 addition, they do not mean that prostaglandins or leukotrienes do not
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stimulate AM’s or TII cells in general. Indeed, Fournier et al. (1999) have reported an
increase in alpha 1-acid glycoprotein (AGP), which is induced during pulmonary
inflammation, upon adding PGE2 to AM’s in vitro. Also, whereas Christman et al.
(1991) have shown an increase in chemotactic activity in AM’s in vitro upon adding
LTB4, they reported a suppression of the chemotactic activity by adding PGE2 to
endotoxin-stimulated AM’s. It appears, therefore, that the response to mediator
treatmentdepends on both the cell types studied and the end point measured.
3C-Inhibitors experiments (done in AM/TII transwells under basal conditions): Different
inhibitors were added to the AM/TII transwell medium to assess the role of the inhibited
substance on AM/TII interaction and thus try to see if the inhibited substance is/are
mediator(s) in AM/TII intercellular communication. Inhibitors used were: NAC(nonspecific antioxidant (Kang et al., 2000)), Vitamin C(non-specific antioxidant (Chen et al.,
1998)), SOD(superoxide inhibitor (Li et al., 1999)), catalase (hydrogen peroxide inhibitor
(Li et al., 1999)), NDGA (lipoxygenase inhibitor (Dubois et al., 1989)), indomethacin
(cycloxygenase inhibitor (Peden et al., 1984)), anti-TNF-α (TNF-α neutralizing antibody
(Barrett et al., 1998)), and anti-IL-1β (IL-1β neutralizing antibody (Yang et al., 1999))
All inhibitors significantly decreased AM/TII transwell basal potentiation. These
results suggest that oxidants, TNF-α, IL1β, prostaglandins and leukotrienes, somehow
contribute in the pathway of AM/TII intercellular communication.
Conclusions:
After having compared the release of several inflammatory mediators from AM’s, TII,
and RLE-6TN cells and different AM/TII co-culture settings under the same culture
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conditions, same exposures (basally, or following LPS or silica exposures) and same cell
concentrations, the following statements could be safely stated:
1) Although AM’s were generally found to release more inflammatory mediators than TII
cells following LPS or silica exposures, TII cells clearly produced significant levels of
mediators which could be capable of contributing considerably to lung inflammation and
injury.
2) Since the RLE-6TN TII cell line responses to LPS and silica exposures were generally
considerably less intense and required higher doses of stimulant than those measured in
primary TII cells, RLE-6TN cells may not be a good substitute for primary TII cells in
studying the pulmonary epithelium.
3) LPS was found to be a more potent inducer of inflammatory cytokines from AM’s,
TII, and RLE-6TN cells. However, silica was found to be as potent as LPS or even
slightly more potent as an inducer of cellular oxidants, especially from TII cells.
4) Surfactant appears to be an inhibitory mediator released from TII cells and acting on
AM’s.
5) Basal transwell co-culture conditions are better than mixed co-culture conditions to
study AM/TII cell interactions since the inhibitory effect of the surfactant in the transwell
co-culture is minimized.
6) AM/TII cell interaction is very specific for the cell type used, (i. e., primary vs. cell
line) and for exposure conditions, among other factors.
7) Oxidants, TNF-α, IL1β, prostaglandins and leukotrienes, probably do not directly
affect the AM/TII intercellular interaction; instead, they (and especially TNF-α) appear
to indirectly modulate the complex pathway(s) of the AM/TII communication.
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